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Abstract
Organelle dynamics of cardiac muscle were studied using fluorescent 
Ca^ "^  indicators and a bioluminescent Ca^ *^  probe, namely aequorin that was 
targeted to SR.
Enzymatically dissociated adult cardiac myocytes were subjected to 
prolonged Incubation with acetoxymethyl (AM) derivatives of Fura-2, 
FuraFF and MgFura-2 which each have different Ca "^" affinities. This 
prolonged incubation allowed indicator loading into sub-cellular 
compartments. Permeabilisation with saponin and subsequent washout 
removed cytosolic component of the indicator. Results from the fluorescent 
indicator studies can be summarised as follows
1. Studies with Fura-2-AM loaded cardiomyocytes revealed the 
existence of a sub-cellular compartment or compartments, which 
exchanges Ca "^" passively with a very slow time course. The identity 
of this is unclear, although likely candidates include mitochondria 
and nuclear envelope
2. The signal from FuraFF-AM loaded cardiomyocytes appears to be 
almost exclusively from mitochondria with no contribution by SR.
Parallel studies were done with SR vesicles and mitochondria prepared 
from cardiac tissue. Mitochondrial signals were very similar to that from 
permeabilised cells. However, SR vesicles loaded with FuraFF-AM did not 
appear to be responsive to changes in external [Ca^'']. The inability of AM 
loading to introduce dye with Ca^^ sensitivity into SR vesicles may be a 
consequence of low esterase activity. This may explain the lack of a clear 
SR signal in measurements from permeabilised cells.
An adenovirus vector was developed to allow over-expression of the 
bioluminescent Ca^^ sensitive protein aequorin specifically targeted to SR 
(Ad-CSQ-Aeq). Experiments were carried with these over-expressing cells 
in the presence of 5|iM ruthenium red and therefore absence of RyR2 Ca^* 
flux. [Ca^^cYT was clamped at 162nM and 380nM. Under these conditions
[Ca^^sR was measured as 5.20 ± 0.230 x 10"  ^M ([Ca^*]cYT =162nM, n=6) 
and 1.21 ± 0.180 x 10'^ M ( [C a ^ Y i =380nM, n=14).
The relationship between [Ca^ '^jsR and rate of Ca^^ uptake in the absence 
of RyR2 flux, revealed a non-linear lumenal dependence. High [Ca^^sR 
has a negative feedback effect upon SERCA2a resulting in a slower rate of 
Ca '^" uptake. The non-linearity of the lumenal dependence suggests a 
mechanism other than a simple trans-SR gradient.
Analysis of leak in the presence of 25pM thapsigargin and 5pM ruthenium 
red indicates a simple linear relationship between [Ca '^"]sR and the rate of 
Ca "^" leak. The kinetics of this relationship suggests a simple leak ‘channel’ 
or pathway, the identity of which is unclear. It is unlikely to be via RyR2 or 
reverse mode of SERCA2a due to presence of inhibitors.
On the basis of a mean uptake and leak uptake curve an estimate of the 
equilibrium value of [Ca '^"]sR in absence of RyR2 activity is approximately 
960pM.
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Chapter 1 - General Introduction
has a pivotal role in the control of cell function. It is employed as an 
intracellular signal to regulate an array of diverse processes including 
fertilization, excitation-secretion coupling in secretory cells, proliferation, 
neuronal excitability and excitation-contraction coupling (EC-coupling) in 
muscle. Indeed Ca^ "" was described as being a “Life and death" signal 
(Berridge MJ et a i, 1998).
1.1 in Cardiac EC-Coupling
Extensive research has allowed a greater understanding of the role that Ca^  ^
plays in cardiac EC-coupling. During each cardiac action potential, 
sarcolemmal L-type Ca^^ channels are activated as the result of propagation of 
the action potential along the T-tubule. This generates an influx of Ca^" into the 
cytosol (see figure 1.1). In most cases this signal is amplified by additional
■
Ca^^ release from the Sarcoplasmic Reticulum (SR) via the Ca^  ^ release 
channels or Ryanodine receptors (RyRs). There are currently 3 schools of 
thought as to how Ca^^ is released from the SR. The first of these postulated 
mechanisms involves electrical coupling wherein Ca^ "^  release is initiated when 
the SR membrane is depolarised by charge movements related to the passage 
of the action potential across the adjacent plasma membrane (Levi at a/.,
1993). The second involves mechanical coupling wherein passage of the
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action potential across the plasma membrane causes a shift in an intrinsic 
membrane protein that effectively “unplugs" a channel, allowing Ca^ "" to flow 
out of the SR (Ferrier & Hewlett, 2001). The third and most widely accepted 
mechanism is known as Ca^^ Induced Ca^^ Release (CICR). Subsequent 
released Ca^ "^  binds to the Ca^^ sensor Troponin C to activate the contractile 
proteins.
Extracellular [Ca "^"] declines to resting levels to allow relaxation by virtue of the 
Sarcoplasmic/Endoplasmic Reticulum Ca^" ATPase (SERCA) and the Na-Ca 
Exchanger that allows the SR to re-sequester Ca^ "" or extrude it from the cell 
(Niggli E, 1999).
C l  eh i n  mi l l  (DHPR i n d  RyR)
C l  pump Ml  C I• x c h i n g i r
Cont r i e t l l i  p r ot i i n iC l  pump
T tu bu l l  I S i r c o l i m m I
Figure 1.1. movements during E-C coupiing.
T-tubule: transverse tubule, DHPR: Dihydropyridine receptor, RyR: Ryanodine 
receptor.
1.2 Ca^* Poois, Uptake and Release
Within the cell Ca^^ is stored mainly in the Endoplasmic Reticulum 
(Sarcoplasmic Reticulum in muscle cells) and secretory granules. Mitochondria
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also have the ability to accumulate Ca^ "^ , but had previously not been 
considered as a significant buffer of intracellular Ca^ "". The 
Endoplasmic/Sarcoplasmic Reticulum is regarded as the most important 
intracellular store in terms of Ca^ "" signalling, because it contains a large 
amount of Ca^ '*' and is able to exchange Ca^’*' quickly with the cytosol (Williams 
& Ashley, 1989).
1.3 Sarcoplasmic Reticulum
The Sarcoplasmic Reticulum (SR) of muscle is a specialized form of ER and 
forms an entirely intracellular membrane system that surrounds the cell’s 
contractile apparatus. The system also forms specialized junctional regions 
with the sarcolemma at the cell surface and within the cell interior at the level 
of the transverse tubules (Williams & Ashley, 1989).
Resident in the SR is a Ca^ "" store that is released into the sarcoplasm after 
electrical excitation ultimately leading to activation of the contractile machinery. 
Therefore it is essential that Ca^ "" uptake and release by the SR and hence the 
sarcoplasmic [Ca "^"], is tightly controlled. [Ca^''] inside the SR (Intraluminal 
Ca^’*'), is in essence determined by 2 or possibly three factors summarised in 
figure 1.2; the rate of influx by SERCA, the rate of efflux via RyR and possibly 
a passive leak pathway.
,Ca-
PumpSR
Luminal >,  Ca"* Ca'
Passive 
Leak ^ Channel
Figure 1.2. Routes of uptake and release from SR.
Channel corresponds to the ryanodine receptor, pump corresponds to SR-Ca^’*' 
ATPase.
The dynamics of the storage and release of Ca^ "^  in the ER and SR have been 
extensively studied. As shown above, generally the results from single cells 
have been interpreted in terms of a global organelle containing various routes 
fro efflux and influx. However recent work on cultured rat astrocytes and 
arterial myocytes suggests that Ca^ "^  stores are organised into small, spatially 
distinct compartments that function as discrete units, further supporting the 
notion that cells can generate spatially and temporally distinct Ca^ "^  signals to 
control individual Ca^’^ -dependent processes (Golovina & Blaustein, 1997).
1.3.1 SERCA
Influx of Ca^" into the SR occurs through the Sarcoplasmic/Endoplasmic 
Reticulum Ca^^-ATPase (SERCA) which translocates 2 Ca^^ ions driven by the 
hydrolysis of ATP.
At least three species of SERCA exist. SERCA 1 is expressed in fast twitch 
skeletal muscle, while the SERCA 2 gene encodes two alternatively spliced 
products, SERCA 2a and 2b. SERCA 2a is expressed in cardiac and slow-
10
twitch skeletal muscles; SERCA 2b in smooth muscle and non-muscle tissues 
(Tada & Toyofuku, 1996).
SERCA2a is a monomer of 100 kDa and is predominantly expressed in 
cardiac muscle (Greene et al., 2000).
In recent years SERCA2a expression in relation to the incidence of disease 
has been the subject of intense study. For example it has been demonstrated 
that delayed cardiac relaxation in failing hearts has been attributed to a 
reduced activity of SERCA2a (He eta!., 1999).
SERCA2a is regulated by the concentrations of Ca^ "^  at the cytosolic face and 
within the SR and by the phosphorylation state of the protein Phospholamban 
that is integral to the SR. In the unphosphorylated state, phospholamban 
inhibits SERCA2a by reducing it’s affinity for Ca^^ (Hajjar RJ et a!., 1997). 
Three sites of Serine/Threonine phosphorylation have been identified 
at Ser-10, Ser-16 and Thr-17. Ser-10 phoshorylation occurs via Protein Kinase 
C (PKC), Ser-16 by PKA, PKG or PKC, Thr-17 by CaM Kll. p-Adrenergic 
stimulation also results in Ser-16 and Thr-17 phosphorylation. The 
consequence of Ser-16 and Thr-17 phosphorylation is an increase in Ca^  ^
pump activity (Colyer, 1998).
1.3.2 Ryanodine Receptor
Ryanodine receptors (RyRs) or SR Ca^^ release channels are ultimately 
responsible for the transient elevation of cytosolic Ca '^" following muscle cell 
depolarization (Conklin MW et a!., 1999). Several studies have suggested that
11
these channels have a bell-shaped sensitivity to the cytosolic [Ca '^"]; at low 
concentrations, Ca^ "" promotes release, while higher concentrations are 
inhibitory (Chen et ai, 1993).
The receptor protein itself has been identified as a highly acidic 
homotetramer, with a total molecular mass of -2.3 MDa and reacts specifically 
with Ryanodine, a highly toxic alkaloid (Gyorke 1 & Gyorke S, 1998) &
(Szegedi C et at., 1999).
RyR cDNA was expressed in the COS-1 cell line and it was found that the 
protein formed channels sensitive to adenine nucleotides and Ryanodine 
confirming the involvement of RyR in Ca^ '*’ release from the SR (Chen et ai,
1993).
Three isoforms of RyR have been identified. Type 1 RyR (RyRi) is primarily 
expressed in skeletal muscle. Type 2 (RyRa) is the primary isoform in heart 
and is involved in the E-C coupling in cardiac muscle and Type 3 (RyRs) is 
expressed predominantly in non-muscle tissues (Murayama T et a i, 1999).
The RyR2 isoform predominantly in cardiac muscle exists as a homotetrameric 
complex. The complex itself includes accessory and other proteins. These 
include cAMP-dependent protein kinase (PKA), Calcineurin 
(Protein phosphatase 2a) and Protein phosphatase 1. The complex is tethered 
to each RyR subunit via the anchor protein mAKAP. A simplified diagram of 
the complex is shown in figure 1.3.
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Figure 1.3 The Ryanodine receptor protein complex.
Shown is one half of the tetrameric complex Proteins are as follows:
Ryanodine receptor protein (RyR2), calsequestrin, calcineurin (PP2A), cAMP- 
dependent protein kinase (PKA), A-kinase anchor protein (mAKAP), triadin, 
calmodulin and sorcin.
RyR and its properties have been studied extensively using biophysical and 
molecular biological techniques (Meissner, 1994). Purified skeletal and cardiac 
SR membrane vesicles have been incorporated into reconstituted membrane 
systems and the conductance studied at the single channel level under voltage 
clamp conditions and also radioligand binding assays using labelled 
Ryanodine. These studies have enabled researchers to relate the activity of 
single ryanodine receptors to global changes in the SR Ca^'’ permeability
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(Alverez J et a i, 1999), (Meissner ef a/., 1988), (Lai et a!., 1988) & (Coronado 
et a i, 1994).
1.3.3 FK Binding Proteins
The FK binding proteins (FKBPs) are a family of low molecular weight proteins 
which bind to the immuno-suppressant drugs FK606 and rapamycin, the best 
characterized of these have been FKBP12.0 and FKBP12.6. Both proteins 
bind to rapamycin and the resulting complex binds to and inhibits calcineurin, 
the knock on effect being inhibition of the immune response (Brillantes et al.,
1994) Co-localization of RyRi and FKBP 12.0 was first demonstrated in rabbit 
skeletal muscle as the physiological role of these proteins was previously 
unclear (Jayaraman et al., 1992). FKBP12.0 was found to be bound at a 
stoichiometry of 4 per receptor, therefore 1 molecule per RyR monomer. 
Binding of FKBP12.6 to RyR2 has been shown to be regulated by 
phosphorylation. Phosphorylation by PKA, which is present in RyR2 complex 
causes dissociation of FKBP12.6 and destabilization of the channel complex 
(Marx ef a/., 2000).
Both FKBP12.0 and FKBP12.6 consist of 108 amino acids, with FKBP12.6 
differing from FKBP12.0 by 18 amino acid residues. Both FKBP isoforms have 
been shown to associate with RyRi. However, FKBP12.6 binds specifically to 
RyR2 . Studies using mutants indicated that specificity is conferred by only 3 
amino acid residues (Xin et a i, 1999).
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There is evidence that FKBP12.0 alters the kinetics of RyR activity and 
induces coupled gating of individual RyRi channels (Valdivia, 1998) & (Marx et 
al., 1998).
The physiological role of FKBP12.6 has previously been poorly understood 
with conflicting evidence regarding its role. Single channel recordings using 
RyR2 incorporated into planar lipid bilayers indicate that removal of FKBP12.6 
using rapamycin or FK506 increases the open probability of the channel and 
induces long-lasting sub-conductance states (Kaftan et a/., 1996) & (Xiao et 
al., 1997). Intriguingly, in parallel studies using cardiac SR preparations, 
removal of FKBP12.6 from the RyR2 or addition of recombinant FKBP12.6 to 
preparations that had previously had FKB12.6 removed, did not alter channel 
behaviour (Timerman etal., 1996) & (Bargefa/., 1997).
Adenovirus-mediated gene transfer has been used to over-express FKBP12.6 
in adult rabbit cardiac myocytes and its effect on RyR2 mediated Ca '^" leak 
from SR examined. It was shown that contractile parameters of isolated 
cardiac myocytes overexpressing FKBP12.6-GFP were altered. Fractional 
shortening, expressed as a percentage of diastolic cell length and therefore 
the contractility, was 21% higher than in cells overexpressing green 
fluorescent protein (GFP) alone, the control virus. In addition to this it was also 
demonstrated that FKBP12.6 overexpressing cells present a 53% reduction in 
leak through RyR2 . This was coupled with the result that indicates a higher SR 
Ca^”^ load. These two results indicate that FKBP12.6 stabilizes the closed 
conformation state of RyR2. This could provide a mechanism by which SR-
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leak is reduced. The consequence of which being increased SR- Ca^^ 
release and myocyte shortening (Prestie et af., 2001).
1.3,4 Catsequestrin
In addition to the proteins shown above there are others which have been 
found to be associated with the RyR2 complex. One of the most important of 
these is the non-EF hand Ca^’*' storage protein calsequestrin.
Calsequestrin is present in the lumen of the SR and was first identified in 1971 
(MacLennan & Wong, 1971). It's major functional role is to buffer transported 
Ca^^ by serving as an intravesicular sink and thus to facilitate active transport 
(Ikemoto N et ai., 1989).
Coincidentally calsequestrin has also been shown to be present at very high 
levels in terminal cisternae giving rise to the hypothesis that calsequestrin 
sequester Ca^^ to sites of Ca^^ release. The importance of calsequestrin and 
it's role in regulating Ca^^ homeostasis within SR is further supported by the 
fact that when skeletal muscle SR is treated with RyR agonists, the expected 
decrease in lumenal [Ca '^"] is preceded by an a transient increase in [Ca^*] 
suggesting reciprocal coupling between RyR and calsequestrin (Ikemoto N et 
a!., 1989).
The protein itself contains 109 amino acids with a large proportion of acidic 
residues and has an approximate molecular mass of 60 kDa (Jones LR eta!.,
16
1998) & (McCleod et al., 1991). Calsequestrin exists in cardiac and skeletal 
muscle isoforms encoded as products of separate genes (Cala & Miles, 1992). 
Rabbit cardiac calsequestrin was cloned and characterised from an adult 
rabbit cardiac cDNA library and in addition the tissue specific expression in 
rabbit heart was studied (Arai et al., 1991). Later research investigated the 
regulation of Ca^ "*” signalling in a transgenic mouse model overexpressing 
calsequestrin. The development of a transgenic mouse overexpressing cardiac 
calsequestrin allowed for the first time, the probing of the role of calsequestrin 
at the cellular level and showed that this protein is closely and functionally 
linked to the Ca^^-release process. In whole cell voltage-clamped transgenic 
myocytes, Ca^’*’ channel gated Ca^^ release from the SR was strongly 
suppressed. Intriguingly, the proteins involved in the Ca^  ^ release cascade 
were down-regulated, whereas Ca^’*' uptake proteins were unchanged or 
slightly increased. This suggests that calsequestrin is indeed linked to SR Ca^^ 
uptake and release (Jones LR et al., 1998). Further studies have suggested a 
role for calsequestrin in these processes.
In a different study it was demonstrated that Ca^’*' release from SR vesicles 
was abolished by selective depletion of calsequestrin. The amount and rate 
constant of Ca^’*' release was investigated as a function of the extent of Ca^’*’ 
loading. It was found that the amount of Ca^^ released increased 
monotonically In parallel to SR Ca^^ loading. Furthermore also the rate 
constant of Ca^  ^ release increased at partial SR Ca^" loading and decreased 
on further SR loading. One can assume that most of the intravesicular Ca^ "^  is
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bound to calsequestrin, therefore these results suggest that the kinetic 
properties of induced Ca^^ release show significant variation depending on the 
level of Ca^^ bound to calsequestrin at the time of induction of Ca^^ release 
(Ikemoto N et a i, 1989).
Calsequestrin had been shown to be a target of Casein Kinase II and recent 
research links the phosphorylation state of the protein to SR Ca^^ release. 
Results from this work showed that depending on the phosphorylation state, 
calsequestrin selectively controls the activity of RyR2 at ImM free lumenal 
[Ca^"']. Calsequestrin in the dephosphorylated state enhanced the open 
probability of the channel implying that dephosphorylated calsequestrin 
regulates Ca '^  ^ release from the SR. This correlates with the fact that 
calsequestrin has been found to exist in close proximity to RyR2. Binding of 
Ca^ "" to calsequestrin leads to conformational changes in RyR2. As 
calsequestrin exists mainly in the phosphorylated state in SR (Szegedi C etaL,
1999), this would imply that dephoshorylation by a phosphatase of 
calsequestrin is a major physiological event and may be part of an as yet 
unidentified Ca^ "" responsive signalling cascade within the SR.
1.3.6 Lumenal Control of uptake and release
The precise mechanism by which lumenal [Ca^^] is controlled is not fully 
understood. The regulation of steady state filing in SR using isolated SR 
vesicles has been studied. This study demonstrated that lumenal [Ca^ "^ ] is 
limited by the concentrations of ATP and ADP (Inesi G & de Meis, 1989) Later 
research studied the effect of changes in SR lumenal [Ca^ "^ ] on Ca^ '*' release in
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single cardiac release channels. Increasing Ca^ "" on the lumenal side of 
the channel increased the open probability. The relative effect of lumenal 
[Ca^’^ j was greater at low levels of cytoplasmic [Ca^^] than at high levels of 
cytoplasmic [Ca^”"], suggesting that SR Ca^^ release channels are modulated 
by lumenal [Ca "^"] (Lukyanenko V et a!., 1996) in addition to the kinetics of the 
SR Ca^  ^pump (Inesi G & de Meis, 1989).
Additional studies of the factors that determine the control of lumenal [Ca '^ ]^ 
have produced variable and contradictory results. These include increased 
Ca^ *" release channel activity by increasing lumenal [Ca^"] (Ikemoto N et al., 
1989), decreased Ca^ "" release channel activity with increased lumenal [Ca^ "^ ] 
(Fill et al., 1990) and a biphasic relationship (Tripathy & Meissner, 1996). 
Possible mechanisms have been postulated to explain the observed effects. 
The first mechanism involves direct action of Ca^^ itself on the Ca^^ release 
channel primarily on the lumenal side of the channel. The other direct 
mechanism suggested is action of Ca^ "^  being released from channel 
accessing the release channel on the cytosolic side. In addition to these two 
mechanisms it has also been suggested that there is somehow indirect 
involvement of lumenal proteins such as Calsequestrin (Kurebayashi N & 
OgawaY, 1998).
The relationship between cytoplasmic [Ca^^] and lumenal [Ca^^] was studied 
and the results indicated heterogeneous Ca^^ binding sites within the SR. The 
study concluded that lumenal [Ca^^] might have a negative regulatory effect on
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the release channel. This negative effect can be explained in two ways. 
Firstly, Ca^ "^  flowing out of the SR has access to cytoplasmic inactivation sites, 
or Ca^" may effect the release channel indirectly via interacting proteins, the 
most promising candidate being Calsequestrin (Kurebayashi N & Ogawa Y, 
1998).
The idea of cytoplasmic inactivation sites is supported by a different study 
investigating the effect of lumenal [Ca^^] on single Ca^^ release channels. 
Results suggested that lumenal [Ca "^"] has the ability to regulate Ca^ "" release 
channels by passing through the open channel and binding to cytoplasmic 
inactivation sites in addition to activation sites which are of low and high affinity 
respectively (Xu L & Meissner G, 1998).
However research by a different group provided contradictory evidence. Again 
the effect of lumenal [Ca^ "^ ] on Cardiac Ca^ "^  release channel was investigated. 
At low lumenal [Ca "^"], increasing the cytosolic [Ca^*] caused a gradual 
increase in the channel open probability by increasing the frequency of 
channel openings. Conversely, elevating the lumenal [Ca^""] caused a gradual 
decrease in the channel open probability. The result of this work rule out the 
possibility that lumenal [Ca2+] acts by interacting with the cytosolic inactivation 
site of the channel. This is because lumenal Ca^”" would only have access to 
the cytosolic side when the pore is open, but when the channel closes, the 
local Ca^ "^  gradient dissipates very rapidly. Therefore rebinding of Ca^^ to the
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channel is unlikely. Also experiments using a fast Ca^ "" chelator such as 
BAPTA at the cytosolic side had no significant impact on the results.
It has been suggested that the SR Ca^* release channel is an aliosteric 
enzyme and modulation involves a lumenal regulatory site. If such a 
mechanism exists, then lumenal [Ca^ "^ ] relieves inhibition caused by high 
cytosolic [Ca^'‘] therefore allowing cells to self regulate the activity of the 
release channel according to SR load (Gyorke I & Gyorke S, 1998).
One of the biggest breakthroughs in understanding how lumenal [Ca^^j 
influences total SR [Ca^ '*'] content was the result of research which led to the 
identification of a Protein Kinase. This so called ‘state of filling’ (SOP) kinase 
was found to be activated by depletion of SR Ca^”", the principal substrate of 
which is the SR membrane spanning protein Phospholamban. Phosphorylation 
of phospholamban promotes Ca pump activity and therefore stimulates store 
refilling, intriguingly, increasing SR Ca load was found to inhibit this protein 
kinase activity associated with the SR. This was demonstrated by reduced 
phosphorylation of phospholamban. This could possibly be due to inhibition of 
a protein kinase or activation of a phosphatase (Singh Bhogal M & Coiyer J, 
1998). This may represent an as yet unidentified signalling cascade present in 
the SR.
1.4 Mitochondria
Previously it was widely accepted that mitochondria did not act as a significant 
buffer of cellular Ca^^ at ‘normal’ cytosolic [Ca^’*"], the exception being stressed
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or damaged cells. Indeed it was believed that mitochondria were too slow to 
effectively compete with ER/SR. Studies in recent years have provided 
contradictory evidence to this. The current understanding of the identified 
mitochondrial influx and efflux pathways and their physiological significance is 
discussed. The major influx and efflux pathways are summarised in figure 1.4.
Ca"" NaC a ^ ^  mPTP —
-  ^ m +
Ca^* Na^
Figure 1.4 The major Influx and efflux pathways.
1. Uniporter (mUP), 2. Sodium/Ca^^ exchanger (mNCX) & 3. Permeability 
transition pore (mPTP).
1.4.1 Mitochondrial Ca^  ^ Influx pathways
At present two pathways of Ca^^ influx into mitochondria have been identified; 
the Ca^^ uniporter (CaUP) and a Rapid influx pathway (RaM). The first inkling 
that mitochondria may have a role, as a Ca^^ buffer was the result of studies 
carried out using agonists of Gq coupled receptors. These studies 
demonstrated that the subsequent IP3 generated not only led to the expected
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release from ER, but in addition led to an increase in [Ca^"”] within the 
mitochondrial matrix (Pozzan T etal., 2000).
1.4.1.1 Uniporter (CaUP)
Studies of passive mitochondrial swelling found that the swelling was observed 
where charge and pH balance were maintained. This led to the Identification of 
an uptake mechanism, the kinetics of which were consistent with a uni porter 
(Gunter et al., 2000).
The influx is downhill and is driven by the large inside negative potential A'Pm 
(Babcock & Hille, 1998).
Characteristics of the Uniporter
The uniporter is inhibited by:
• Ruthenium Red (as a non-competitve inhibitor)
• Protonophores such as Carbonyl Cyanide m-Chlorophenolhydrazone 
(CCCP) that collapses the proton motive force.
• The novel inhibitor diaminopentane pentamine cobalt (DAPPAC) (Duchen 
MR, 2000)
Is activated by:
• Spermine
• Taurine
it is modulated by Adenine nucleotides. The uptake rate is near zero for 
external [Ca "^*] less than 200-300nM (Gunter ef a/., 2000).
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1.4.1.2 Rapid Uptake Mode (RaM)
Intriguingly, uptake via RaM is inhibited very soon after it has begun, after a 
fraction of a second when the predominant pathway becomes CaUP
Characteristics of RaM
The rate of uptake decreases dramatically when cytosolic [Ca^ *^ ] is below 100- 
125nM.
Uptake via RaM is inhibited by;
• Uncouplers that dissipate the membrane potential, indicating like CaUP the 
thermodynamic driving force for uptake is the electrochemical gradient
• Ruthenium Red although the concentration required is 100 fold greater 
than for inhibition of CaUP (Gunter et al., 2000).
It is unknown whether or not RaM involves an alternative conformation of the 
uniporter and the mechanisms are one in the same, although evidence would 
suggest that they are related.
Possibly some of the most intriguing results in recent years came from a study 
offering a direct comparison of heart and liver mitochondria. It was shown that 
in heart mitochondria AMP, which had no effect on liver mitochondria, inhibited 
RaM. Results also showed a differing sensitivity to Ruthenium red (RuR) 
between mitochondria from the different tissues. In heart, there were two sub­
populations of mitochondria: one that was stained by RuR and one that was 
resistant and showed no inhibition of RaM by RuR. The respiratory control
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ratios of mitochondria sensitive to RuR staining were less than those resistant 
to RuR staining suggesting that mitochondria resistant to RuR staining include 
a greater proportion of damaged mitochondria.
1.4.2 Mitochondrial efflux pathways
There are two major efflux pathways for Ca^ "^  in mitochondria, Na^ dependent 
and Na^ independent. The major difference between these two mechanisms is 
the fact that the Na^ independent also allows transport of IVIn^ "^  whereas the 
Na"" dependent mechanism does not (Gunter et al., 2000). They also show 
very different kinetics.
1.4.2.1 Na"^  independent
This mode of efflux is dominant in tissues where ion clearance is important 
such as liver and kidney. Ca^ "" is exchanged from the mitochondrial matrix for 
nH^ ions against an electrochemical gradient . Studies have suggested that 
n=2 (Gunter etal., 2000) & (Rizzuto R et al., 2000).
This is an active process supported by the fact that it is inhibited by CN" .Other 
inhibitors of this process are;
• Low levels of uncouplers such as CCCP
• High concentrations of Ruthenium Red
1.4.2.2 Na* dependent
The levels of expression of this mechanism vary in different types of tissue and 
correspondingly Vmax also varies. These values are very high in heart, where 
rapid release of Ca^* may be important. 1 Ca^* is exchanged for 3 Na* ions. 
There are many inhibitors of the process including:
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• Tetraphenyl phosphonium
• Trifluoroperazine
• Diitiazem
• Verapamil
• Clonazepam
1.4.3 Permeability transition pore
In addition to the fore-mentioned efflux, there also exists a mitochondrial 
permeabiltiy transition pore (mPTP) the physiological significance of which 
remains largely unknown. The pore comprises a complex consisting of a 
voltage-dependent anion channel, the adenine nucleotide translocase and 
cyclophilin-D. Under pathological conditions associated with ischaemia and 
repurfusion, the complex ‘deforms’ into the PTP allowing free permeation of 
low molecular weight solutes (Buntinas et al., 2001).
The pore is a voltage-dependent, non-seiective channel, which is activated by:
• Matrix Ca^*
• Inorganic phosphate
• Oxidants such as peroxides
and is inhibited by
• Matrix H*
• Cyclosporin A that requires ADP and Mg^* for inhibition (Rizzuto R et al., 
2000).
Studies have also suggested that Cyclosporin A is not specific for mPTP and 
also interferes with other signalling processes (Duchen MR, 2000).
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1.4.4 Are these routes of influx/efflux of physiological significance?
Perhaps the most obvious consequence of an alteration in the Ca^* content of 
mitochondria is the regulation in metabolism. Three key enzymes of the Krebs' 
cycle: pyruvate-, isocitrate- and a-keto glutarate dehydrogenases are all 
activated by an increase in mitochondrial matrix [Ca^*]. Other loci within the 
metabolic pathways such as the electron transport chain are also suggested to 
be Ca^* control points.
In recent years studies have revealed that mitochondria are key players in the 
induction or amplification of the processes leading to programmed cell death or 
apoptosis (Gunter ef a/., 2000).
1.4.4.1 Mitochondria as amplifiers of Ca^* signals?
It has been shown that IPs induced Ca^* mobilisation also results in Ca^* 
induced Ca^* release from the mitochondria (mClCR). mClCR appears to be 
dependent on transitory opening of the PTP operating in a low conductance 
mode. This release from mitochondria therefore results in an amplification of 
Ca^* signals from ER (Ichas F et al., 1997). This is further supported by the 
suggestion that regions of the ER are in close proximity to mitochondria 
suggesting cross-talk between the two organelles (Pozzan T et a i, 2000) & 
(Pozzan & Rizzuto, 2000).
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1.5 Analysis of dynamic Ca^* signais
1.5.1 Fluorescent Indicators
Measurement of [Ca^*] within cells is made possible by the use of fluorescent 
dyes, the use of which was revolutionised by Grynkiewicz and colleagues 
(Grynkiewicz G et a/., 1985). These dyes show a spectral response upon 
binding Ca^* and fall into two categories: single wavelength intensity 
modulating dyes and dual wavelength ratiometric dyes.
Single wavelength indicators exhibit changes in the intensity of their 
fluorescence excitation and emission spectra, whereas ratiometric indicators 
exhibit intensity as well as spectral changes upon binding to Ca^*. Ratiometric 
dyes have the advantage of allowing fluorescence intensity measurements to 
be taken at two different wavelengths to obtain a ratio. The ratio minimises the 
effect of artefacts unrelated to changes in [Ca^*].
It is possible to measure [Ca^*] within compartments of cells using cell- 
permeant acetoxymethyl (AM) ester derivatives of these dyes that are loaded 
into cells, wherein cleavage to cell-impermeant products occurs by the action 
of intracellular esterases. Permeabilisation and subsequent washout of the 
cytosolic component renders the dye trapped within sub-cellular compartments 
(Meldolesi & Pozzan, 1998), (Golovina & Blaustein, 1997) & (Mogami H et ai, 
1998).
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1.6.2 Protein-Based Ca^* Indicators
Another method of quantitatively measuring intracellular Ca^* is using the 
photoprotein Aequorin that was originally isolated from the jellyfish Aequorea 
Victoria. Release of blue light occurs upon binding Ca^*, the intensity of which 
is proportional to [Ca^*]. This indicator’s usefulness was limited by the need to 
microinject the protein into living cells making fluorescent dyes the method of 
choice for measuring intracellular [Ca^*]. Subsequent cloning of the aequorin 
cDNA has expanded the possible uses of this photoprotein. Development of 
aequorin specifically targeted to sub-cellular locations has permitted the 
measurement of [Ca^*] within organelles (Brini M et a!., 1996), {Robert et ai, 
1998) & (Brini M et a!., 1997). However, the major drawback of targeted 
aequorin is that the bioluminescent signal itself is rather weak. Therefore the 
signal has to be recorded from populations of cells rather than single cells.
1.5.2.1 Chameleons
The inability to effectively record Ca^* signals in single cells using targeted 
protein based indicators has recently been somewhat overcome with the 
development of fluorescent indicators based on Green Fluorescent Protein 
(GFP). Dubbed ‘Chameleons' these indicators take advantage of Fluorescence 
Resonance Energy Transfer (FRET) between different coloured GFP mutants 
(Miyawaki A et a!., 1997). Chameleons can be targetted to organelles in the 
same way as aequorin, but they exhibit much brighter fluorescence. Therefore 
signals can be recorded from single cells.
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These indicators comprise chimaeric proteins and are tandem fusions of a 
blue- or cyan-emitting mutant of GFP, calmodulin, the calmodulin binding 
peptide M13 and an enhanced green- or yellow- emitting GFP. Binding of Ca^* 
causes calmodulin to wrap around the M13 domain, increasing the 
fluorescence resonance energy transfer (FRET) between the flanking GFPs.
Different ranges of free [Ca^*] can be measured by employing a range of 
calmodulin mutations. This indicator was used to visualise free Ca^* dynamics 
in the cytosol, nucleus and endoplasmic reticulum in single HeLa cells (Cala & 
Miles, 1992) . The major advantage of using chameleons include the fact that 
the method is mainly non destructive to cells therefore making in vivo work 
easier, although the cytotoxicity of GFP has been under much scrutiny (Liu et 
ai., 1999). Also the detection method does not require additional cofactors, as 
is the case with aequorin.
1.5.2.2 Pericams
A major problem with using the described chameleon indicators and indeed 
the GFP variants that form the basis of these proteins, are their thermostability 
of folding and pH sensitivity (Tsien RY, 1998). Even small changes in pH can 
effect its fluorescence spectrum dramatically. Another limitation with 
monitoring Ca^* dynamics in the cytosol is the large size of the expressed 
chameleon.
These problems have led to the development of another class of proteins 
indicators, namely pericams. These indicators are based on circularly 
permuted GFP variants. It was previously believed that any rearrangements or
30
insertions within GFP would drastically decrease the fluorescence due to the 
intricate post-translational modification required of GFP. However, this view 
was altered by the results of a subsequent study. This group discovered that 
when the amino and carboxy portions were interchanged and with short spacer 
peptides the fluorescent properties were maintained (Baird et al., 1999). They 
also found that insertion of calmodulin in YFP had enhanced fluorescent 
properties that could be used to monitor cytosolic Ca^* changes. Nagai and 
colleagues have further developed these indicators.
The basis for their indicators was circularly permuted yellow fluorescent protein 
(YFP) (cpYFP). cpYFP was fused to calmodulin and it’s target peptide M l3. 
Three types of peri cam were obtained by mutating several amino acids 
adjacent to the chromophore. Of these, "flash-pericam" became brighter with 
Ca^*’ whereas "inverse-pericam" dimmed. Finally, "ratiometric-pericam" had an 
excitation wavelength changing in a Ca^*-dependent manner. The pericams 
were expressed in HeLa cells and were able to monitor free Ca^* dynamics, 
such as Ca^* oscillations in the cytosol and the nucleus.
Ca^* dynamics in the nucleus and mitochondria were simultaneously measured 
by using ratiometric-pericams having the appropriate localization signals 
(Nagai etal., 2001)
The mitochondrially targeted ratiometric pericam has been used to monitor 
beat to beat oscillations in mitochondrial [Ca^*] in neonatal ventricular 
myocytes (Robert et al., 2001) In addition a ratiometric pericam has been
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fused to another protein to allow specific studies of the generation of Ca^* 
microdomains to influence cell function (Pinton etal., 2002)
1.6 Aims of thesis
A considerable amount is known about cytoplasmic and sarcolemmal control 
of Ca^* fluxes. However little is known about how [Ca^*] within the lumen of the 
SR exerts its effect on SERCA2a and RyR2 activity. Several studies have 
presented indirect evidence of lumenal [Ca^*] effects. (Lukyanenko V et al., 
1996;Tripathy & Meissner, 1996)&(Xu L & Meissner G, 1998). The majority of 
these previous studies have used lipid bilayer preparations and the results 
have provided contradictory and variable results. The reason for the wide 
range of published results is unknown. It may be based on transport protein 
subtypes, or differing isolation procedures for isolation of the proteins. 
Although a good model system, it is not known how functional these transport 
proteins are in the lipid bilayers and if the correct accessory proteins are 
present in the complexes in the correct conformation.
The original aim of studies for this thesis was to use low sensitivity Ca^* 
indicators to measure [Ca^*] within the lumen of SR in adult cardiac muscle. 
This approach using acetoxymethyl (AM) derivatives of these indicators has 
been used to study ER Ca^* dynamics in non-muscle cells (Golovina & 
Blaustein, 1997) (Mogami H et al., 1998) and SR Ca^* dynamics in smooth 
muscle (Shmigol et al., 2001)
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To date, no work has been directed toward adult cardiac muscle. The main 
reason for this Is due to lack of a specific indicator. I have shown in one of the 
chapters of this thesis that when adult ventricular myocytes are exposed to 
prolonged incubation with acetoxymethyl derivatives of FURA-based indicators 
almost the entire signal is attributed to mitochondria with virtually no 
contribution by SR. An alternative approach was used to measure lumenal SR 
[Ca^*]. An adenovirus was generated to allow the expression of an indicator 
within the SR. This proved to be the most effective approach
The purpose of measuring the [Ca^*]sR was to correlate SERCA2a and RyRa 
activity with lumenal Ca^* and to ascertain some of the factors that limit [Ca^*] 
within the SR of cardiac muscle. Correlation of uptake or release processes 
with intra-SR [Ca^*] may reveal lumenal control over these processes. 
Furthermore, measurement of the free Ca^* within the lumen would begin to 
address the debate concerning the factors that limit [Ca^*]. This work could 
provide a clearer understanding of the process of excitation-contraction 
coupling in cardiac muscle in health and disease. Ultimately this may possibly 
reveal alternative routes to safely enhance cardiac SR function in disease 
states such as heart failure.
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Chapter 2 
General Methods
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Chapter 2- General Methods
2.1 Preparation of Adult Cardiac Myocytes
For the investigations carried out for this thesis, adult cardiac myocytes were 
prepared from rabbit and rat. Experiments were performed on both freshly 
prepared cardiac myocytes and those that had been maintained in culture for 
several days. All procedures were undertaken in accordance with the United 
Kingdom Animals (Scientific Procedures) Act 1986.
2.1.1 Preparation of Adult Rat Cardiac Myocytes
White Wistar male rats were stunned by a blow to the head and killed by 
cervical dislocation. The thoracic cavity was opened, the heart quickly excised 
and placed into a beaker containing ice-cold Krebs’ solution (120mM NaCI, 
20mM HEPES, 5.4mM KCi, 0.52mM NaH2P04, 3.5mM MgCl2.6H20, 20mM 
Taurine, lOmM Creatine, 11.ImM Glucose, pH 7.4).
The excised heart was quickly mounted and tied via the aorta onto the cannula 
of a Langendorff retrograde perfusion system. Fat and connective tissues were 
trimmed away. 50mL of Ca^* free Krebs’ solution, maintained at 37°C was 
perfused through the heart at a rate of 13mL/min to wash out blood and Ca^*. 
The heart was then perfused with Gollagenase/Protease solution (3mg 
Protease and SOmg Collagenase dissolved in 25ml Ca^* free, sterile Krebs' 
solution). The enzyme solution was collected as it passed through the heart 
and re-circulated after the initial volume of the solution had passed through.
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Re-circulation of the enzyme solution and hence the digestion, was continued 
for approximately 16 minutes until the heart felt soft to the touch. The enzyme 
solution was washed out of the heart by perfusion with 50mL Sterile Krebs’ 
solution containing ImM EGTA.
The heart was excised and placed into Krebs’ solution containing ImM EGTA. 
The tissue was then finely chopped. The myocytes were dissociated by lightly 
titurating the solution using a plastic pasteur pipette. The dissociated cardiac 
myocytes were filtered through gauze mesh to remove undigested and other 
tissues. The cells were then counted using a haemocytometer and the 
concentration adjusted to 1 x 10^ ceils/ml. The two sub-populations of cells 
rod-shaped and ball shaped were deemed ‘live’ and ‘dead’ respectively. Dead 
cells being cells having undergone hyper-contraction.
2.1.2 Preparation of Adult Rabbit Cardiac Myocytes
White New Zealand male rabbits were subjected to deep anaesthesia with an 
intravenous injection of 600 U Heparin together with an overdose of Sodium 
Pentobarbitone (100mg/kg) via the left marginal ear vein. Animals were 
deemed terminally anaesthetised when both stretch and corneal reflex were 
absent. The thoracic cavity was opened, the heart quickly excised and placed 
into a sterile beaker containing sterile, ice-cold Krebs’ solution (120mM NaCI, 
20mM HEPES, 5.4Mm KCI, 0.52Mm NaH2P04, 3.5Mm MgCl2-6H20, 20mM 
Taurine, lOmM Creatine, II.Im M  Glucose, pH 7.4).
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The excised heart was quickly mounted and tied via the aorta onto the cannula 
of a Langendorff retrograde perfusion system. Fat and connective tissues were 
trimmed away. 200mL of Ca^* free Krebs’ solution, maintained at 37°C was 
perfused through the heart at a rate of 25mL/min to wash out blood and Ca^*. 
The heart was then perfused with Collagenase/Protease solution (3mg 
Protease and 50mg Collagenase dissolved in 75ml Ca^* free, sterile Krebs’ 
solution).
The enzyme solution was collected as it passed through the heart and re­
circulated after the initial volume of the solution had passed through. Re­
circulation of the enzyme solution and hence the digestion, was continued for 
5-6 minutes until the right ventricular (RV) tissue felt softened to the touch. The 
enzyme solution was washed out of the heart by perfusion with lOOmL Sterile 
Krebs’ solution containing 1%(w/v) Bovine Serum Albumin (BSA).
The RV was excised and into Krebs’ solution containing 1mM EGTA. The 
tissue was then finely chopped. The myocytes were dissociated by lightly 
titurating the solution using a plastic pasteur pipette. The dissociated cardiac 
myocytes were filtered through gauze mesh to remove undigested and other 
tissues. The cells were then counted using a haemocytometer and the 
concentration adjusted to 1 x 10^ cells/mL.
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2.2 Primary Myocyte Culture
Rabbit and rat cardiac myocytes were prepared as above under sterile 
conditions with some subtle changes to the methods. All solutions had 
previously been filtered sterilised and prepared with sterile water and 
autoclaved glassware. Perfused tissue was cut down and placed in a solution 
containing 1% BSA (w/v) in sterile glassware and the tissue finely chopped 
using autoclaved instruments in a laminar flow hood. The chopped tissue was 
then placed in tissue culture grade sterile flasks and placed on a shaker at 
room temperature for 1 hour.
The following steps were performed using aseptic technique in a laminar flow 
hood. The supernatant was removed and placed into sterile 15mL centrifuge 
tubes. The cells were allowed to sediment by gravity. The supernatant was 
removed and the pellet resuspended in Krebs’ solution containing 100(aM 
CaCb. Again the cells were allowed to sediment by gravity, the supernatant 
removed and the pellet resuspended in Krebs' solution containing 250plVI 
CaCb. This step was repeated twice more and successively raised the 
extracellular Ca^* to SOOp-M and then 1mM.
The cells were counted using a haemocytometer, subjected to gentle 
centrifugation and the pellet resuspended in M199 medium (supplemented 
with 312.5mg Taurine, 600mg D,L Carnitine, 327.5mg creatine, 6mL pencillin/ 
streptomycin per 500mL) to a concentration of 1 x 10^ ceils /mL.
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2.2.1 The Use of Laminin as a Substrate for Cell Attachment
35mm petri dishes with coverslips (Mattek corporation, Ashland, USA) were 
treated with the following laminin concentrations: Ijng/mL, 3pg/mL and 5pg/mL 
in order to optimise cell attachment conditions. The laminin solutions were 
prepared by the addition of Laminin stock solution (1mg/mL) to M199 medium 
according to table 2.1.
Final [Laminin] 
(pg/mL)
Volume Img/mL Laminin stock solution 
added /mL Ml 99 (mL)
1 1.0
3 3.0
5 5.0
Table 2.1. Volumes of Laminin required to give particular concentrations
Cells were plated at a density of 1x 10"^  cells /cm^ onto the 35mm dishes pre­
treated with laminin, which corresponds to a concentration of 1x 10® cells /mL. 
The dishes were then incubated in a 37°C incubator supplemented with 5% 
CO2 for 4 hours to allow cell attachment.
The dishes were washed to remove unattached cells by decanting the medium 
using an automatic pipette, adding fresh Ml 99 and decanting this. 2mL of 
fresh Ml 99 was then added to each dish and the cells placed in a 37°C 
incubator.
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2.3 Studying Calcium dynamics in cardiac myocytes
2.3.1 Loading of Cardiac Myocytes with Acetoxymethyl Esters of 
Fluorescent Calcium Indicators
Acetoxymethyl (AM) Ester derivatives of fluorescent calcium indicators are cell 
permeant and thus if cells are incuabted with the derivatives for a significant 
time, dye molecules will eventually make their way into sub-cellular 
compartments. The action of cellular esterases causes cleavage of the AM 
grouping. The cleaved product is not membrane permeant and therefore this 
renders the dye trapped within sub-cellular compartments and cytosol. 
Addition of a permeabilising agent such as p-escin or saponin removes 
cholesterol moieties from the sarcolemma and leaves approximately 60p 
holes. These holes allow cytoplasmic component of cleaved dye to leave. Dye 
loaded into sub-cellular compartments remains.
Dissociated Cardiomyocytes were incubated in the above Krebs’ solution 
containing 1mM EGTA with 10pM of Fura-2-AM, FuraFF-AM or MgFura-2-AM. 
Incubations were carried out for 90 minutes in 25mL Tissue culture-grade 
flasks in a 37°C incubator. This was followed by a 30-minute indicator free 
incubation at room temperature to allow dye cleavage by cellular esterases.
Cells were then permeabilised by brief exposure to either p-escin or saponin 
(0.1mg/mL). The cell concentration was adjusted to 0.5 x 10® cel I s/m L 
(previously optimised) and were then placed in a cuvette containing a mock 
intracellular solution of the following composition: 5mM EGTA, 25mM HEPES,
40
5.5mM MgCb, lOOmM KCI pH 7.0. Free [Ca^*] was monitored by the addition 
of Fluo-3 tetrapotassium salt.
2.3.2 System for studying Calcium dynamics on populations of cells
A closed cuvette system was used to study the calcium dynamics on 
populations of cells. A diagram of which is shown in figure 2.1.
AM loaded, permeabiiised Rat Cardiac myocytes
Light 340nm, 
380nm 
485nm
Stirrer
Figure 2.1. Cuvette based system for studying Ca^* dynamics on 
populations of cells.
Measurements were made using a closed cuvette system shown in figure 2.1. 
Fluorescence intensity due to excitation at 488nm for fluo-3  and fluorescence 
ratio due to excitation at 340 and 365nm for the FURA dyes were recorded 
digitally. 365nm is used in preference to the conventionally used 380nm  
because when a fluo-3 based dye is used in conjunction with a FURA dye, 
there tends to be contamination of the 380nm signal by the fluorescence due
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to excitation of the Fiuo dye. This effect is minimised using an excitation 
wavelength of 365nm. This wavelength is close to the isobestic point of Fura 
dyes so provides little information on ion concentration, but still provides a 
reference signal.
2.4 Generation and Propagation of Adenovirus to aliow up-regulation of 
Cardiac specific proteins
An adenovirus was generated to allow expression of indicator targeted to the 
SR. Specifics of the generation are described in detail in chapters.
Two methods were used to carry out large-scale preparation of adenovirus, 
each with subtle differences.
2.4.1 Method 1
Carried out in the laboratory of Professor Gerd Hassenfuss, Gottingen 
Hamster embryonic kidney (HEK) 293 cells were cultured in IMDM (with 8% 
foetal calf serum (FCS)) in T-75 flasks. When cells had reached 90% 
confluence they were passaged by trypsin treatment and plated out onto 40 
fresh 15cm tissue culture petri dishes. Medium was removed and replaced 
daily. 3 days later when the cells had again reached approximately 90% 
confluence they were infected with each of the adenoviruses with an 
multiplicity of infection (MOI) of 1 assuming 5x10® cells per 15cm plate. Virus 
was added to IMDM (with 5% FCS) and this was subsequently used to infect 
the HEK 293 cells. The infected cells were incubated at 37°C for 2 hours. The 
virus-containing medium was removed, the plates washed with 1x phosphate 
buffered saline (PBS) and the medium replaced (IMDM, 5% FCS).
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2-3 days after infection when the cells had started to detach from the surface 
of the plate, the medium containing the detached cells was decanted into 
250mL centrifuge tubes. A 20% stock of NP-40/PBS solution was added to a 
final concentration of 0.1%. The tubes were then allowed to shake at room 
temperature for 30 minutes. After shaking, the tubes were centrifuged at 
11,000rpm at 4°C for 25 minutes in a JA14 rotor. The supernatants were 
transferred to new 260mL centrifuge tubes and added to each tube was a half 
volume of 20% (w/v) PEG 8000/2.5mM NaCI solution. The tubes were then 
packed in ice and water and stored at 4°C for 4 hours without shaking.
The samples were centrifuged at 11,000rpm at 4°C for 25 minutes in a JA14 
rotor. The pellet was resuspended in 5mL 1x PBS per 250mL tube. The 
resuspended viral pellets were passed through a 24G needle into 15mL falcon 
tubes and incubated shaking at 4°C for 1.5 hours. This was followed by 
centrifugation at 6,000 rpm for 10 minutes. The supernatant was then 
transferred to a 50mL falcon tube and CsCI added to give approximately 
1.32g/mL based on the measured volume. ImL of the solution was weighed 
and the CsCI concentration adjusted to 1.32-1.34 mg/mL if required either on 
addition of CsCI or 1x PBS. The solution was then transferred to 13mL 
sealable ultracentrifuge tubes. Pairs of tubes were balanced on addition of pre­
made sterile 1.33mg/mL CsCI solution using a syringe and needle. The tubes 
were then sealed and subjected to ultracentrifugation at 40,000 rpm at 16°C 
overnight.
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The band on the gradient corresponding to the infectious viral particles was 
removed using a 19G needle and placed in a sterile eppendorf tube. CsCI was 
removed from the prepared adenovirus by dialysing for approximately 6 hours 
in dialysis tubing placed in 5x PBS (pH 8.0). The PBS was removed and 
replaced and the preparation allowed to dialyse overnight. The prepared 
adenovirus was removed from the dialysis tubing.
The number of particles present was ascertained by diluting the virus 1:1000 
and measuring the optical density at 260nm (ODzsonm) assuming that OD26onm 
=1.0 for 1 X 10^° parti cl es/mL. Glycerol was added to the prepared adenovirus 
to a final concentration of 10% and suitable aliquots prepared and stored at - 
80°C.
2.4.2 Method 2
Carried out in the laboratory of Dr. Andrew Baker, University of Glasgow. 
Another method of large scale preparation was used to prepare large amounts 
of the adenovirus. A pure high titre stock of Ad-CSQ-Aeq was generated by 
the following method which is modified version of a well established method by 
Nicklin and Baker. In essence, the process involved co-transfection of HEK 
293 cells with the viral plasmid pJM17 and a plasmid containing the cDNA 
encoding the SR-targeted Aequorin. Homologous recombination follows within 
the HEK 293 cells. This leads to cell lysis that is observed under the light 
microscope as a clear area on the HEK 293 monolayer. This clear area termed 
a plaque. There are also cell morphology changes, which is termed the 
cytopathic effect. Once the cytopathic effect has been observed, the cell lysate
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is harvested and the resulting recombinant adenovirus extracted using a 
solvent, (adenovirus has no release mechanism from cells).
Culture and passage of HEK 293 cells
HEK 293 cells at a low passage number were cultured in minimal essential 
medium (MEM) supplemented with 10% FCS, 2mM L-glutamine, 100 
international units (IU))/mL penicillin and 10O^ig/mL streptomycin in T-150cm^. 
When cells had reached 100% confluence, in other words when the whole 
surface of the flask was completely covered with cells, 5mL 1x citric saline 
solution was added to the flask ensuring the whole surface was covered. The 
flask was incubated at room temperature for approximately 10 minutes. The 
cells were detached by gently tapping the surface. 5ml MEM (with 
supplements) was added to this and any resulting cell clumps re-suspended. 
2mL of cell suspension was added to fresh, sterile T-150cm^ flasks. To each 
flask was added approximately 25mL MEM.
Following the observed plaques cytopathic effect, the cell lysate was removed 
and placed in a sterile 50mL falcon tube. The flask was then washed with 5mL 
MEM and pooled with the cell lysate. This was then subjected to centrifugation 
at 250g for 10 minutes at room temp. The resulting pellet was resuspended 
inlmL sterile Phosphate buffered saline (PBS). An equal volume of the solvent 
ArkloneP was added to this suspension. The tube was inverted for 10s 
followed by shaking for 5s. This mixing step was repeated. The tube was 
centrifuged at 750p at room temperature for 15 minutes. At this point the tube 
contained 3 layers: the lower layer solvent, the middle layer cellular debris and 
the top layer aqueous solution that contains adenovirus. The top adenovirus
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layer was removed using a sterile pipette and stored in sterile eppendorf tubes 
in 50\xL aliquots at -80°C
2.4.2.1 Generation of plaque pure stocks by end point dilution
Plaques may occur as a result of multiple recombination events within the HEK 
293 cells. When working with adenovirus it is vital to have “pure” stocks i.e. 
that have been generated by the multiplication of a single adenovirus. A simple 
method of plaque purification is serial dilution of the crude stock onto the HEK 
293 cells.
Low passage HEK 293 cells were sub-cultured into a sterile 96 well plate that 
consists of 8 rows each containing 12 wells. Cells had reached 50-60% 
confluence by the following day. Serial dilutions of the crude adenovirus stock 
were made according to table 2.2.
Row on plate Final dilution of 
virus
Volume of virus 
(pL)
Volume of media 
( fL )
10'^ 50 stock 4950
1 10-4 50 @10'^ 4950
2 10’® 50 @ 10-4 4950
3 10^ 500 @ 10'“ 4500
4 10"® 500 @ 10"' 4500
5 10'* 500 @ 10-“ 4500
6 10^" 500 @ 10-“ 4500
7 10-11 500 @ 10^° 4500
8 control 0 5000
Table 2.2. Dilutions of Adenovirus to perform plaque assay
46
starting with row 8, the media was removed using a 200^L pipette tip and 
replaced with 100 p.L fresh media. The media in row 7 was then replaced with 
the correct adenoviral dilution. This was repeated for rows in ascending order. 
The plate was placed in a 37°C incubator. 16-18 hours post-infection the 
media was replaced with 200^L of complete media both removing and 
replacing the media with a fresh sterile pipette tip per well. The media was 
replaced every 2-3 days for 8 days, each time the media was changed the 
plate was monitored using the light microscope.
Once the cytopathic effect was apparent in a well, it was marked and replacing 
of the media was ceased in that well. On the seventh day of the assay another 
96 well plate was prepared. On the eighth day, once the assay was completed, 
the cells and media was collected from three positive wells at the highest 
dilution for which the cytopathic effect is present. Pipetting up and down three 
times collected the cells. Two of the samples were then stored in sterile 
eppendorf tubes at -80°C. The remaining sample was extracted using an equal 
volume of the solvent ArkloneP as described previously. 50pL of this 
adenovirus stock was then used to repeat the plaque purification assay using 
the 96 well plate prepared on day 7. Plaques taken from the highest dilutions 
on this plate were considered plaque pure.
2.4.2.2 Generation of high titre stocks of adenovirus
This is achieved by large-scale multiplication of the initial pure recombinant 
adenovirus in HEK 293 cells.
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Low passage HEK 293 cells were sub-cultured until there was 30 T-150 tissue 
culture flasks. Once the cell monolayer had reached 80-90% confluence they 
were deemed ready for infection. Infection was carried out by mixing 50^L of 
crude adenovirus plaque-pure stock with 750mL complete media and adding 
25mL to each flask. The media was changed every 3 days until the cytopathic 
effect began and the cells started to detach from the flask. At this point in the 
procedure the cells were collected and placed in sterile 50mL falcon tubes. 
The cells were then centrifuged at 250g for 10 minutes at room temperature.
All of the resulting pellets were resuspended in a total volume of 15mL PBS. 
To this was added an equal volume of the solvent ArkloneP. The tube was 
inverted for 10 seconds followed by shaking for 5 seconds. The 
inversion/mixing step was repeated, this was followed by centrifugation at 
750g for 15 minutes at room temperature. The top layer containing adenovirus 
was removed and transferred to a fresh tube. A further lOmL of PBS was 
added to the remaining solvent and cell debris and the extraction repeated.
This was followed by CsCI density gradient centrifugation as described 
previously in method one earlier in this chapter.
2.4.2.1 Determining the plaque forming units (pfu) value
Before using the pure recombinant adenovirus is was necessary to ascertain 
the infectivity. This followed the same method as that used to perform plaque 
purification by end point dilution described previously in this chapter. Serial 
dilutions were made of the purified adenovirus as described In the table earlier
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in this chapter. lOOpL of each dilution was added to the appropriate wells and 
incubated in a 37°C incubator for 16-18 hours. The media was then changed 
and 200 i^L complete media added. The media was changed every 2-3 days. 
Once the cytopathic effect was evident in any well, It was marked and the 
replacing of the media ceased. After 8 days the number of wells containing 
plaques were counted and fitted to the equation below in order to calculate the 
adenoviral titre.
proportionate distance = %positive above 50-50%
% positive above 50%-positive below 50% 
log IDso (infectivity dose) =
log dilution above 50% + (proportionate distance x -1)x dilution factor 
e.g.
10""^  all wells positive 10/10 
10’® 10/10 
10'^ 10/10 
10'® 9/10 
10'® 3/10 
10'^ ® 0/10 
10'^  ^ 0/10
proportionate distance = 90-50
90-30 
= 0.67
loglDso = -8 + (0.67 x -1 )=  -8.67 
ID5o=10-®-®^
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TClD5o(tissue culture Infectivity dose 60) = 1
10
TCIDso/IOOfiL =
X dilution factor (10)
TCIDso/1 mL = 10®-®^  = 4.67 x 10® TCIDeo/mL 
1 TCIDsosO.y pfu 
final titre= 3.27 x 10® pfu/mL
-8.67
2.5 Statistical Analysis
All data within the thesis are expressed as mean (± SEM) unless stated 
otherwise. AN OVA multi variant analysis (parametric) was used to compare 
multiple groups. A Tukey-Kramer multiple comparisons post test was used, A 
value of p<0.05 was considered statistically significant. A student’s t test was 
used to compare single pairs of data.
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Chapter 3- Use of Fluorescent Indicators to Measure Ca^ "^
3.1 Introduction
It is possible to monitor changes within cells using fluorescent Ca^ "^  
indicators. There are two major classes of fluorescent indicator: single 
wavelength and dual wavelength ratiometric dyes.
A more detailed description of fluorescent Ca^ "* indicators is given in section
1.5.1.
A number of fluorescent Ca^^ indicators were used to monitor the changes in 
intracellular free Ca^T The indicators and some of their properties ascertained 
experimentally are shown in table 3.1.
Excitation
A,(nm)
Emission 
^max (nm)
Kd (pM) Rmin Rmax
Fura-2 340,365 512 0.23 0.50 1.17
Fluo-3 488 526 0.52 1.00 16.4
FuraFF 340,365 512 10 0.43 1.30
MgFura-2 340,365 511 70 0.53 1.70
MgFluo-4 488 516 120 1.00 908.50
FluoSN* 488 516 220 1.00 55.55
Table 3.1 Properties of the fluorescent indicators.
All were tested and some subsequently used in further studies. * fluorescence 
of ion-free indicator is extremely weak. Ka, Rmin and Rmax were ascertained 
experimentally. Rmin corresponds to the fluorescence ratio or intensity in 
solution containing lOmM EGTA, where [Ca^^] is <1nM and Rmax in a solution 
containing approximately lOmM Ca^^
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3.2 Calibration of Fluorescence
A series of calibration experiments were carried out to establish the 
relationship between [Ca^ "^ ] and fluorescence due to excitation at 488nm or in 
the case of Fura-2 and MgFura-2, the fluorescence ratio due to excitation at 
340 and 380nm. Solutions containing increasing free [Ca^^] were used to 
decipher this relationship. The solutions were prepared by mixing stock 
solutions of 10mM EGTA and 10mM CaEGTA (10mM EGTA/CaEGTA, 
lOOmM KCI, 1mM MgCl2.6H20, 20mM HEPES, pH 7.0) in different ratios to 
give differing free [Ca '^"]. The ratios and free [Ca^T are shown in table 3.2.
Solution (10EGTA:10CaEGTA 
ratio)
Free [Ca^'l
10E O.IOOnM
10:1 42.170nM
3:1 0.126|^M
1:1 0.380pM
1:3 1.140|.iM
1:10 3.428^M
lOCaE 61.680|liM
Table 3.2. Calibration solutions and their corresponding free [Ca^^.
Values calculated using the program React version 3.
Measurements were made using a closed cuvette system described in section
2.3.2. 150pL of each of the solutions from table 3.2 was added to 1350^L
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0.05R solution (O.OSmM EGTA, 1mM MgCb, 10mM NaCI, 25mM HEPES, pH 
7.0) with 10pM of the relevant dye. The fluorescence intensity or fluorescence 
ratio in the case of the ratiometric dyes was recorded digitally. These values 
were used to construct calibration curves using the computer software 
Microcal Origin. The data collected was fitted to curves using a logistic 
method. Curves of fluorescence or fluorescence ratio versus [Ca^"], whichever 
is applicable to each dye, were displayed on one graph and are shown in 
figure 3.1.
•  MgFluo-4
Combined Free Acid Calibrations ^ Pluo-3 ,  fiuoSN
+ mgfura x  Fura-2
r ' "m ' '"Mr ' ""m '  ........  ' ""M
1E-11 1E-10 IE-9 1E-8 1E-7 IE-6 1E-5 IE-4 1E-3 0.01 0.1 1
[Ca'l
Figure 3.1. Graph showing combined calibration curves for each of the 
free acids.
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3.3 Use of two indicators simultaneously to monitor [Ca^T changes
Since the ratiometric indicators (Fura-2 and MgFura-2) and the single 
wavelength indictors (Fluo-3, MgFluo-4 and Fluo5N) use different excitation 
wavelengths, it is possible to use single wavelength and ratiometric indicators 
simultaneously. Spectra were produced for each indicator by scanning 
between 300 and 600nm and are shown in figures 3.2A-E.. ‘High Calcium’ 
indicates use of a 10mM CaEGTA solution giving a free [Ca^^] of 61.68|liM and 
‘Low Calcium’ 10mM EGTA and 0.1 nM.
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Figure 3.2A-3.2E.
Emission spectra of the fluorescent indicators Fura-2, MgFura-2, FluoSN, 
MgFluo-4 and Fluo-3 measured at >520nm.
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Chapter 4-Use Of Fluorescent Indicators To Study Organelle 
Ca^  ^Dynamics In Cardiac Muscle
4.1 Introduction
The [Ca^^] within sub-cellular compartments exerts an effect on diverse cellular 
processes such as ATP synthesis, protein processing and secretion of 
secretagogues from secretory cells. These processes have been subject to 
intense study in a variety of cell types. However the details regarding the 
precise regulation of organelle [Ca '^ ]^ within cardiac muscle remains unclear, 
this area is reviewed in detail in chapter 1 general introduction. Studies carried 
out using dissociated adult cardiac myocytes from rat investigating organelle 
calcium dynamics will be detailed and discussed.
The aim of this study was to examine the signals from fluorescent dyes loaded 
into the organelles of cardiac muscle. Insights into the types of compartments 
loaded with dyes were gleamed using a series of experimental interventions 
each using a permeabiiised cell population to allow manipulation of the 
cytosolic [Ca '^*'] which are detailed as follows:
1. Recording of signals in response to an increased extracellular [Ca^'‘] highly 
buffered using EGTA
2. The effects of ionophore A23187 to dissipate any [Ca^ "^ ] gradients across 
all organelle membranes
3. Use of specific inhibitors to abolish any active organelle Ca^ "^  accumulation
(a) Thapsigargin for SR
(b) A cocktail of compounds to prevent mitochondrial Ca^^ uptake
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The suitability of two main types of Ca^ "^  indicator were investigated in 
preliminary studies; Fluo-based and several FURA-based dyes. Fluo-based 
dyes have several advantages, (i) Their use to study intra-ER and intra-SR 
dynamics has been well documented, (Shmigoi et ai, 2001) & (Shmigol et ai, 
1999) (ii) Their long excitation wavelengths {approximately 490nm) reduces 
intrinsic fluorescence problems such as autofluorescence and (iii) The large 
change in fluorescence intensity over the Ca^^-sensitive range of the dye 
should help distinguish signals from small discrete regions of the cell.
However initial experiments with the Fluo-dyes were unsuccessful primarily 
due to poor loading relative to the Fura-based dyes but the main problem 
being artefactual changes in fluorescence unrelated to changes in [Ca "^"] but 
due to photobleaching or chemical quench.
Fura-based dyes appeared to load into cells/organelles more effectively and 
provided a ratiometric fluorescence signal that was unaffected by artefacts due 
to photobleaching and/or chemical quench.
The following results describe studies that were carried out in order to 
characterise organelle Ca^ "" dynamics in cardiac muscle using the 
acetoxymethyl (AM) derivatives of Fura-2, FuraFF and MgFura-2. The dye 
Fluo-3 was included in the mock intracellular solution in some experiments to 
allow the simultaneous monitoring of the cytosolic [Ca^ "^ ].
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4.2 Methods
Adult rat cardiac myocytes were prepared as described in the chapter 2, 
general methods.
4.2.1 Loading of Cardiac Myocytes with Acetoxymethyl Esters of 
Fluorescent Calcium Indicators
The protocol used to load cardiac myocytes with acetoxymethyl ester 
derivatives of fluorescent Ca^^ indicators is described in detail in section 2.3.1.
Figure 4.1 is a confocal fluorescence trace of a representative Fluo-3-AM 
loaded cardiomyocyte treated with the permeabllsing agent p-escin. On 
addition of the agent, there is a significant decline in the total cellular 
fluorescence. There is however, a significant level of fluorescence remaining, 
which can be attributed to indicator trapped within sub-cellular 
compartments/bound to cellular proteins or structures.
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Figure 4.1 . Confocal fluorescence trace following the progression of 
permeabilîsatlon
Confocal fluorescence trace monitoring the progress of permeabilîsatlon of a 
representative Fluo-3-AM loaded cardiac myocyte. The cell was initially 
exposed to a solution containing lOmM EGTA for the period marked above the 
trace. At the point indicated, the cell was perfused with the same 10mM EGTA 
solution containing 100pg/mL p-escin. Circles on the trace denote when 
images shown in figure 4.2 where taken.
Figure 4.2 depicts images of representative Fluo-3~AM loaded cardiac 
myocytes taken before and after treatment with the permeabilising agent p -  
escin. The rapid decline in fluo-3 fluorescence indicates that the majority of 
cleaved fluo-3-AM free in the myoplasm leaves, in theory, the remaining cell 
fluorescence is due mainly to indicator trapped within organelles/bound to 
cellular structures.
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Before permeabilisation After permeablisation with 
0.01 mg/mL p-escin
250
Figure 4.2. Confocal images of Fluo-3-AM loaded cardiomyocytes
Taken before and after permeablisation. The time points at which these 
images were acquired are shown on the graph in figure 4.1 denoted by the 
circles.
Dissociated Cardiomyocytes were incubated in the fore-mentioned Krebs’ 
solution containing ImM EGTA with lOpM of either Fura-2-AM, FuraFF-AM or 
MgFura-2-AM. Incubations were carried out for 90 minutes in 25mL Tissue 
culture-grade flasks in a 37°C incubator. This was followed by a 30-minute 
indicator free incubation at room temperature to allow dye cleavage by cellular 
esterases.
Cells were then permeabiiised by brief exposure to either p-escin or saponin 
(0.1 mg/mL). The cell concentration was adjusted to 0.5 x 10® cells/mL 
(previously optimised) and were then placed in a cuvette containing a mock 
intracellular solution of the following composition: 5mM EGTA, 25mM HEPES, 
5.5mM MgCb, lOOmM KCI pH 7.0. 4.2.2 System for studying Calcium 
dynamics on populations of cells
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4.2.2 System for studying Calcium dynamics on populations of cells
Three different Fura based dyes were used in these studies; Fura-2, FuraFF 
and MgFura-2 which have different Kd values for Ca^^ and therefore diifferent 
Ca^ '*' affinities. Thus, it is possible to monitor changes within a cell in response 
to an identical manoeuvre, i.e. if there is a very large change in [Ca^"] 
occurring in response to the addition of a specific agent, it may be too large to 
be accurately measured with a high affinity indicator. Table 3.1 illustrates some 
of the properties of these 3 Fura dyes.
A closed cuvette system was used to study the calcium dynamics on 
populations of cells. This system is described in detail in section 2.3.2.
4.2.2 System for studying Calcium dynamics on populations of cells
Different compounds were used which specifically prevent active Ca^^ uptake 
by organelles of cardiac muscle.
4.2.3.1 Use of Ionophore A23187
Active accumulation of Ca^"‘ was detected by measuring the effects of the 
addition of the ionophore A23187. This compound binds to membrane systems 
and dissipates the Ca^ '*' and Mg^  ^gradients (Erdahl etal., 1996).
4 2.3.2 Use of thapsigargin
The inhibitor thapsigargin was used to selectively inhibit the SR/ER Ca^" 
ATPase (SERCA) (Hove-Madsen L & Bers DM, 1993).
In these studies thapsigargin was used at a concentration of 25^iM based on 
the measurements of Hove-Madsen and Bers. Using 0.5 x 10® cells this is 
equivalent to 0.9mg of total cell protein. This is approximately 8 times greater
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than the concentration of thapsigargin required to ensure complete inhibition of 
active Ca^^ accumulation by SR via the cardiac muscle isoform SERCA2a.
4.2.3.S Use of inhibitors of mitochondrial Ga *^ accumulation
Experiments were carried out in the presence of the compounds oligomycin 
(IfiM), CCCP (3pM) and rotenone (1|uM).
Oligomycin is a compound that inhibits the F1/F0 ATPase of mitochondria. Use 
of this prevents synthesis of ATP from ADP and Pi and translocation of protons 
from the myoplasm to the mitochondrial matrix. CCCP disconnects the 
electron transport chain from the formation of ATP, which in turn dissipates the 
membrane potential (\j/). Rotenone blocks NADH dehydrogenase (complex 1) 
in the respiratory chain. When used in conjunction with one another this trio of 
compounds should in theory completely abolish active Ca^^ uptake by 
mitochondria. The three mitochondrial inhibitors were used as a cocktail so as 
to ensure complete inhibition of active mitochondrial uptake (Duchen MR, 
1999) & (Boitier E etal., 1999).
4.2.4 Measurement of Rmin and R a^x
Fluorescence ratios were recorded from the cells after loading with each of the 
Fura-based indicators. The changes in ratio represent changes in [Ca^'’] and is
normally converted to [Ca^^] using the following formula (Grynkiewicz G et al.,
1985).
r c a ^ l  =  K .B  (R -R m in )
(Rmax“R )
Where p= (Fluorescence @ 365nm in low fCa^^l 
(Fluorescence @ 365nm in high [Ca ])
K= Dissociation constant for Ca^^
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Rmin was defined as the 340/365nm fluorescence ratio in the presence of 
[Ca^“"] of <1nM in a solution containing 5mM EGTA. Rmax was defined as the 
340/365nm fluorescence ratio in the presence of saturating [Ca^^]. For 
simplicity, in our measurements Kd = (p x K)
Previous work has shown that the value of Kd is altered when the indicator is 
AM loaded within intracellular organelles (Poenie, 1990). We attempted to 
calibrate the intra-organelle indicator using a range of intracellular [Ca^^] in the 
presence of ionophore. This proved unsuccessful for high [Ca^^] due to 
changes in intrinsic cellular fluorescence. Figure 4.3 illustrates how each 
individual wavelength alters and it's subsequent effect on the ratio.
FuraFF 340:365nm fluorescence ratio
10mM i
I
FuraFF individual fluorescence signals
lOtnMCa^"; — 340nm 
365nm
B
Figure 4.3 Fluorescence properties of FuraFF.
Panel A shows the 340nm;365nm fluorescence ratio. Panel B the individual 
wavelengths. lOmM Ca^" is added in the presence of A23187
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In these experiments Rmax was measured just prior to secondary slow 
changes. These slow secondary changes in fluorescence were only observed 
at high [Ca^’'] and prevented calibration of low affinity dyes.
The results presented are the fluorescence ratios normalised to Rmin and Rmax 
using the following relationship:
Normalised ratio = (Ratio-Rmml
(Rmax"Rmln)
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4.3 Results
4.3.1 Effects of ionophore on Fura-based organelie signal
Experiments were carried out with populations of permeablised cells loaded 
with Fura-2-AM, FuraFF-AM and MgFura-AM. A23187 to a final concentration 
of 1pM was added to the cells. Cytosolic [Ca "^"] was buffered using 5-15mM 
EGTA/CaEGTA solutions.
The three sets of studies with cells loaded with the three different dyes all 
followed an identical protocol; cytosolic [Ca^^] was raised from <1nM using 
CaEGTA to give a free [Ca^ "^ ] of 760nM. This was followed by addition of 26|liI\/I 
thapsigargin and then 1 pM A23187. The maximum fluorescence ratio (Rmax) 
was achieved by addition of 10mM CaCbto the cuvette. The experiments were 
repeated in the sustained presence of 1 luM A23187. Tables 4.2 and 4.3 show 
the mean results for each of the three dyes in the absence and presence of 
A23187.
4.3.1.1 Fura-2
Representative traces from experiments carried out with Fura-2-AM loaded 
cells in the presence and absence of A23187 are shown in figures 4.4a and 
4.4b.
Raising the cytosolic [Ca^ "^ ] to 760nM causes a rise in the 340:366 ratio in both 
cases. In the control experiments the mean 340:365 fluorescence ratio 
normalized to Rmin and Rmax is 0.281 ± 0.0067 (n=5) and the presence of 
ionophore 0.426 ± 0.05 (n=7). The presence of A23187 appears to speed up
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the rate of Ca^ "" uptake into a sub-cellular compartment or compartments. A 
significant component of this signal appears to be passive.
4.3.1.2 FuraFF
Representative traces from experiments carried out with FuraFF-AM loaded 
cells in the presence and absence of A23187 are shown in figures 4.5a and 
4.5b. Increasing the extracellular [Ca '^"] to 760nM caused an increase in the 
FuraFF fluorescence ratio. The mean normalized ratio is 0.174± 0.01 (/?=11) 
Subsequent addition of thapsigargin caused a small decrease in the 
fluorescence ratio in the graph shown, but the mean is 0.169+ 0.01 (n=5). This 
is not significantly different from the previous level. A23187 addition caused 
rapid decline in ratio to almost the level of Rmin in the control cells.
Referring to figure 5.5b, A23187 addition with an extracellular [Ca^^] of <1nM 
did not give rise to any significant change in the fluorescence ratio. Raising the 
extracellular [Ca^^] to 760nM caused a small increase in the fluorescence ratio. 
The mean ratio in this case being 0.05 ± 0.009 {n=^0) Addition of thapsigargin 
and additional A23187 caused no further significant changes.
4.3.1.3 MgFura-2
Representative traces from experiments carried out with MgFura-2-AM loaded 
cells in the presence and absence of A23187 are shown in figures 5.6a and 
5.6b.
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In the control experiments, raising free [Ca^"] to 760nM, the mean 
fluorescence ratio is 0.032 ± 0.007 (n=6). In the sustained presence of A23187 
this ratio is 0.015 + 0.007 (/?=5)
Addition of A23187 at the beginning of the protocol results in a decline in 
fluorescence ratio. The normalised ratio is represented as a negative value to 
Rmin- In other words the ratio value is less than the ratio attained in <1nM Ca^’*' 
Raising free [Ca^^] to 0.76|aM, thapsigargin addition or subsequent A23187 do 
not alter the fluorescence ratio significantly. If a passive uptake pathway does 
exist, the MgFura ratio changes would not reflect this as it Is a low affinity 
indicator.
Dye (A) Normalized 
ratio in 
[Ca^*]cY=760nM
(B) Normalized 
ratio 
in 25nM TG
(C) Normalized ratio 
in V M  A23187
Fura-2 0.281±  0,06 
.........('1=5)
0.352+ 0.07* 
(n=6)
0.427+ 0.043 * 
(/)“6)
FuraFF 0.174+0.005
(/7 = 1 1 )
0.169+0.01
(n=5).
0.045+ 0.005* 
(n=11).
M gFura-2 0.032+ 0.007 
(n=6).
0.032+ 0.009 
(/?=6).
-0.076+ 0.01 * 
(n=6).
Table 4.1. Mean normalized fluorescence ratio values.
For tables 4.1, 4.2 and 4.3 values shown in bold with an asterix denote results 
that are significantly different from column A (p<0.05).
71
Dye (A) Normalized 
ratio in 
[Ca^"']oY=760nl\/l
(B) Normalized 
ratio 
in 25nM TG
(C) Normalized 
ratio in li^M 
A23187
Fura-2 0.426+ 0.03 
(n=7)
0.471+0.03
(n=6)
0.506+ 0.03* 
(n=6)
FuraFF 0.055+ 0.01 
(n=10)
0.083+ 0.01 
(n=5).
0.032+0.01*
(n=10).
M gFura-2 0.015+0.007
(n=5).
0.02+ 0.009 
(n=6).
-0.06+ 0.02* 
(n=6).
Table 4.2. Mean normalized fluorescence ratio values for experiments in 
the presence of IfiM A23187.
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Fura-2-AM, Fura-FF-AM, Mgfura-2-AWI loaded Cardiac Myocytes in the 
presence and absence of 1|iM A23187
Fura-2-AM loaded
Figure 4.4a
0.40-
.2 0.35-
£5
e
0.30-CD•P.Ê
<§ 0.25-
PO
0.20-
0.15-
760nMCa^ E
TG
1000s
Figure 4.4b
0.45-1
0.40-
g
1 0.35-
EcinCO 0.30-
ËIZ
3 0.25-CO
0.20-
0.-15-
A23187
760nM ca"
TG
Figure 4.4. Fura-2-AM loaded Cardiomyocytes in the presence and absence of
1|uM A23187. Cell populations were maintained in <1nM [Ca "^"] in SmM EGTA.
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FuraFF-AM loaded
Figure 4.5a
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% 0.30 ■
So
m 0.25
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760nM Ca" TG
A23187
lOirM Ca'
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Figure 4.5b
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760m M Ca" Ÿ / / / / / / / / / / / / / / / / / / / / / / / / / / /7 7 7 Z \  
A23187 /
nr-
lOmMCa"
Figure 4.5. FuraFF-AM loaded Cardiomyocytes in the presence and
absence of 1|iM A23187. Cell populations were maintained in <1nM [Ca^T in
5mM EGTA.
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MgFura-AM loaded
Figure 4.6a
0.3 n
TG
A23187
0 .2 -
200s
0.1 “
0.3-,
Figure 4.6b
0
1§ 0,2 
o
0.1
A23187
760nM Ca'
TG
200s
A23187
Figure 4.6. MgFura-2-AM loaded Cardiomyocytes in the presence and
absence of IpM A23187. Cell populations were maintained in <1nM [Ca^ '*'] in
5mM EGTA.
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4.3.2 Experiments in the presence of mitochondrial inhibitors
Representative traces from the initial experiments carried out with these 
compounds and termed ‘mitochondrial inhibition’ with Fura-2-AM, FuraFF-AM 
and MgFura-2-AM loaded cardiac myocytes are shown in figures 4.7-4.9.
The protocol involved raising the free [Ca^^] to 120nM, 380nM and 760nM 
using buffered EGTA/CaEGTA solutions. In the experiments shown for Fura-2- 
AM loaded cells this protocol only involved one increment in the increase of 
the cytosolic [Ca^^] of 760nM. Table 4.4 shows the mean results for each of 
the three dyes in the presence of IjuiM oligomycin, 3piM CCCP and 1pM 
rotenone.
4.3.2.1 Fura-2
Representative traces from experiments in the absence and presence of the 
mitochondrial inhibitor cocktail with Fura-2-AM loaded cardiomyocytes are 
shown in figures 4.7a and 4.7b. In the presence of the mitochondrial inhibitor 
cocktail (figure4.5b), raising the cytosolic [Ca^T from <1nM to 760nM causes a 
rise in the 340:365nm fluorescence ratio.
4.3.2.2 FuraFF
In FuraFF-AM loaded cells there is a significant difference between control 
experiments and those in the presence of mitochondria! inhibitors as shown in 
figures 4.8a and 4.8b. In the absence of mitochondrial inhibitors (Figure 4.8a), 
raising the cytosolic [Ca "^"] from <1nM in steps to 126nM, 380nM and finally 
760nM each time causes a rise in the 340;365nm fluorescence ratio. In the 
presence of the inhibitor cocktail (Figure 6b) the same manoeuvres also
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causes an increase in the fluorescence ratio but the magnitude Is very much 
smaller. In both sets of experiments thapsigargin addition causes a small 
decrease in the ratio.
4.3.2.3 MgFura-2
Experiments were carried out with cells loaded with MgFura-2-AM shown in 
figures 4.9a and 4.9b. The same protocol was carried out as with the FuraFF- 
AM loaded cells. Raising the cytosolic [Ca '^*'] in the absence and presence of 
the mitochondrial inhibitor cocktail causes virtually no changes in the 
fluorescence ratio. A23187 addition in both cases a large decline in the 
fluorescence ratio to a value far lower than that observed at the beginning of 
the experiment in the presence of 5mM EGTA which conventionally was used 
as a measure of Rmin.
Table 4.4 shows the mean normalized fluorescence ratio values.
Dye (A) Normalized 
ratio in 
[Ca^*]cY=760nM
(B) Normalized 
ratio 
in 25nM TG
(C) Normalized 
ratio in 1|iM 
A23187
Fura-2 0.303± 0.07 
(n=6)
0.37+ 0.08 
(/?=6)
0.489+ 0.02* 
(#7=6)
FuraFF 0.076± 0.001 
(n=15)
0.071+0.014*
(#7=5).
0.056+0.0013*
(#7=15).
M gFura-2 0.023+0.001
{n=6).
0.023+ 0.001* 
(#7=6).
-0.06± 0.01* 
(#7=6).
Table 4.3. Mean nonnalized fluorescence ratio values in the presence of 
oligomycin (1p,M), CCCP (3^M) and rotenone (1pM).
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Fura2-AM, FuraFF-AM and MgFura-AM loaded cardiomyocytes in the 
presence and absence of mitochondrial inhibitors 
Fura-2-AM loaded
Figure 4.7a
0.40
o 0.35 
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^  0.30
Io  0.25 CO
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0.15
yeOnMCa"’
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Figure 4.7b
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7G0nM Ca"
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Figure 4.7. Fura-2-AM loaded Cardiomyocytes in the presence and
absence of 1 pM oligomycin, 3|iM CCCP and 1 pM rotenone Cell
populations, were maintained in <1nM [Ca^^] in 5mM EGTA.
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FuraFF-AM loaded
Figure 4.8a
0.20 •
I
oCO
0 .1 5 -
thapsigargn
A23187
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Figure 4.8b
0 .2 0 -
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mitochondrial inhibition
thapsigargin
A23187
0.12^MCa'* Q.38nM Ca'* 0.7%dV1 Ca'
200s
Figure 4.8. FuraFF-AM loaded Cardiomyocytes in the presence and
absence of 1nM oligomycin, 3|iM CCCP and 1|iM rotenone. Cell
populations were maintained in <1nM [Ca^^] in 5mM EGTA.
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MgFura-AM loaded
Figure 4.9a
0
1
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Figure 4.9b
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Figure 4.9. MgFura-2-AM loaded Cardiomyocytes in the presence and 
absence of 1pM oligomycin, 3|xM CCCP and 1|liM rotenone. Cell 
populations were maintained in <1nM [Ca^T in 5mM EGTA.
8 0
Figures 4.10a-4.10c are a summary of the experiments carried out in the 
presence of mitochondrial inhibitors and A23187. 340:365nm ratio shown is 
the mean ratio normalized to the Rmin and Rmax of each experiment. Figure 
4.10a shows results from the Fura-2-AM loaded cardiac myocytes. The legend 
along horizontal axis refers to addition of either CaEGTA to increase the 
cytosolic [Ca^'^jto 760nM, 25|.xl\/l thapsigargin and SjaM A23187. The presence 
of the mitochondrial inhibitor cocktail or A23187 does not appear to prevent 
uptake into the sub-cellular compartment(s).
Figure 4.10b shows the mean normalized ratios from experiments with 
FuraFF-AM loaded cardiac cells. Presence of mitochondrial inhibitors 
significantly reduces the increases in ratio in response to raising the cytosolic 
[Ca^ "*]. Thapsigargin under all three conditions does not appear to have a 
significant effect on the ratio.
Finally, figure 4.10c depicts average, normalized 340;365nm ratios for 
experiments carried out with Mg Fura-2-AM loaded cells. Looking at the control 
experiments, addition of thapsigargin after raising the cytosolic [Ca^"] to 
760nM appears to have no effect. In the experiments in the presence of 
mitochondrial inhibitors and A23187, thapsigargin leads to a decrease in the 
average normalized fluorescence ratio. Addition of A23187 under all three 
conditions causes a large decrease in ratio to a value below that of the initial 
fluorescence ratio (Rmin).
A semi- quantitative model to help clarify these results is given In appendix I.
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Figures 4.11a-411c show the normalized fluorescence ratio values obtained 
with varying [Ca^^] are shown for each of the three indicators. Data shown are 
from values obtained with the pentapotassium salt (free add, closed drdes), 
AM loaded cardiomyocytes (open squares), AM loaded cardiomyocytes in the 
presence of mitochondrial inhibitors (open cirdes) and AM loaded 
cardiomyocytes in the presence of ionophore A23187 (dosed diamonds).
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Figure 4.10. Mean normalized ratio values for each of the three sets of 
studies with the three different FURA indicators
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Figure 4.11. Calibration curves of the indicators. Also shown population cell 
data. Each of the inidicators shown in panels a-c. Panel d illustrates an expanded 
section of the graph in panel b for FuraFF. This illustrates the estimate of the 
[Ca '^"]mito due to active uptake. The section expanded is shown with a red box.
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4.3.3 Investigating changes in the MgFura-2 signal
In studies with populations of cells that had been loaded with MgFura-2-AM 
the result obtained after addition of 1 i^M A23187 in the presence and absence 
of mitochondrial inhibitors (figures 4.9a and 4.9b) are indistinguishable. The 
dramatic decrease in ratio on ionophore addition cannot be easily explained by 
changes in [Ca^‘*‘]. One possible explanation is changes in [Mg "^"] interfering 
with the signal.
Therefore changes in [Mg^"] within organelles were investigated. Nigericin and 
the respiratory substrates Succinate with Pi are known to increase [Mg^’*'] of the 
mitochondrial matrix ([Mg^ j^m) (Brierley et al., 1987) & (Jung & Brierley, 1994).
These experimental manipulations were used in these studies to alter 
mitochondrial [Mg^^]. Representative diagrams are shown in figures 4.12 and 
4.13. As expected the MgFura ratio increases when both nigericin and 
succinate are added.
Representative trace from experiments carried under the same conditions but 
with FuraFF-AM loaded cells is shown in figures 4.15-4.17. This shows that 
addition of succinate with Pi causes virtually no change in ratio, as is also the 
case with A23187 addition. A subsequent study of the changes occurring with 
[Ca^ "^ ] using the respiratory substrate succinate with added Pi was carried out, 
results of which are shown in figures 4.14 and 4.16. In MgFura-2-AM and
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FuraFF-AM loaded cells were studied. In both sets of experiments presence 
of succinate and Pi accelerates Ca^’*' influx into mitochondria.
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MgFura-AM loaded Cardiomyocytes
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Figure 4.12. MgFura-2-AM loaded cardiomyocytes. Cells were in a mock 
intracellular solution containing 5mM EGTA (see methods for composition) thus 
clamping the [Ca^*] at <1nM.
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Figure 4.13. MgFura-2-AM loaded cardiomyocytes. Cells were in a mock
intracellular solution containing 5mM EGTA (see methods for composition) thus
clamping the [Ca "^"] at <1nM.
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Figure 4.14. MgFura-2-AM loaded cardiomyocytes. Ceils were in a mock 
intracellular solution containing 5mM EGTA (see methods for composition) The 
cytosolic [Ca^T was raised to 760nM prior to succinate addition.
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Figure 4.15. FuraFF-AM loaded cardiomyocytes. Cells were in a mock
intracellular solution containing 5mM EGTA (see methods for composition) thus
clamping the [Ca^ "^ ] at <1 nM.
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Figure 4.16. FuraFF-AM loaded cardiomyocytes. Cells were in a mock 
intracellular solution containing 5mM EGTA (see methods for composition) The 
cytosolic [Ca^""] was raised to 760nM prior to succinate addition.
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Figure 4.17. FuraFF-AM loaded cardiomyocytes. Cells were in a mock
intracellular solution containing 5mM EGTA (see methods for composition) thus
clamping the [Ca^ ""] at <1nM.
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4.4 Discussion
4.4.1 Studies in the presence of ionophore
Figures 4.4-4.6 illustrate the results of studies carried out with populations of 
permeabilised cells loaded with Fura-2-AM, FuraFF-AM and MgFura-2-AM in 
the presence of ionophore. 340:365 fluorescence ratio changes corresponding 
to the changes in [Ca^ "^ ] were markedly different between the populations of 
cells loaded with each of the dyes.
4.4.1.1 Fura-2
In control experiments with Fura-2-AM loaded cells, an example of which is 
shown in figure 4.4a, raising cytosolic [Ca^ "^ ] to 760nM causes a rapid rise in 
the 340:365nm fluorescence ratio which does not reach a steady state. 
Thapsigargin addition has no apparent effect on this signal. However in these 
control experiments addition of A23187 appeared to speed up the exchange of 
Ca^^ and causes a subsequent rise in the 340:365nm ratio to attain a steady 
state value.
Comparing the control experiments to those carried out in the presence of 
A23187 shown in figure 4.4b, raising the cytosolic [Ca^^] to 760nM causes a 
rise in the 340:365nm fluorescence ratio. The magnitude of this rise is greater 
than that observed with the control experiments. Intriguingly in the control 
experiments shown in figure 4.4a, A23187 addition after the 760nM step 
speeds up the rate of equilibration of Ca^”". The ratio change attained is almost 
of the same magnitude of that observed in figure 4.4b after the 760nM step in
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the sustained presence of A23187. Another interesting observation with these 
studies is that thapsigargin addition has no apparent effect on the ratio as is 
the case the control experiments. Previous studies have not identified a 
specific slow exchange compartment. A considerable amount of work has 
used the washout technique to study the different compartments
capable of Ca^ "" exchange. In general, 3 exchangeable compartments have 
been identified. A rapidly exchanging compartment (half time <1s) has been 
attributed to the sub-sarcolemmal junctional region (Post & Langer, 1992). A 
second slower compartment termed “intermediate compartment" could be 
attributed to the SR (half time 19 s). A final third compartment with an 
exchange time of approximately 4 min was attributed to mitochondria (Langer 
et al., 1990). It is conceivable that the slowly exchangeable compartment in the 
current study corresponds to this slow, mitochondrial compartment. 
Interestingly, this component was retained in the presence of mitochondrial 
inhibitors, suggesting that even mitochondria without an active uptake 
mechanism can exchange Ca^ "".
4.4.1.2 FuraFF
Figures 4.5a and 4.5b are representative of the results obtained from 
experiments with FuraFF-AM loaded cells. There is a clear difference between 
the ratio changes in the two sets of experiments.
In the control experiments, a representative result shown in figure 3a, 
increasing the extracellular [Ca^"'] to 760nM caused an increase in the FuraFF 
fluorescence ratio. Subsequent addition of thapsigargin caused a small
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decrease in ratio. A23187 addition caused rapid decline in ratio almost 
equivalent to the Rmin in the control cells.
Referring to figure 4.5b, A23187 addition with an extracellular [Ca^ "^ ] of <1nM 
did not give rise to any change in the fluorescence ratio. Raising the 
extracellular [Ca^"] to 760nM could only elicit a small increase in the 
fluorescence ratio. This rise is almost 50% of the magnitude of the rise 
observed in the absence of ionophore. Addition of thapsigargin and additional 
A23187 caused no further change in the fluorescence ratio.
These results suggest that A23187 dissipates an active [Ca^T gradient 
between compartments and the cytosolic medium within the cardiac cell.
4.4.1.3 MgFura-2
Representative traces from experiments carried out with MgFura-2-AM loaded 
cells in the presence and absence of A23187 are shown in figures 4.6a and 
4.6b. Cardiomyocytes loaded with this dye responded with a small increase in 
fluorescence ratio with increasing cytosolic [Ca^T
Perhaps the most intriguing observation of studies of cells loaded with this dye 
is the fact that thapsigargin failed to have a significant effect on the ratio but 
A23187 caused a rapid decline in the ratio to below the value observed in the 
absence of Ga^ .^ As shown in figure 4.6b, addition of A23187 in the presence 
of low [Ca^’^ j caused a rapid decline the fluorescence ratio that did not change 
on increasing [Ca^^]
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While the results from the studies with Fura-2 and FuraFF are consistent with 
significant passive and active components of Ca^^ accumulation in cardiac 
cells, the response of Mg Fura-2 cannot be explained simply in terms of [Ca^ "^ ] 
within intracellular compartments.
4.4.2 Studies In the presence of mitochondrial inhibitors
Figures 4.7-4.9 illustrate the results of studies carried out with populations of 
permeabilised cells loaded with Fura-2-AM, FuraFF-AM and MgFura-2-AM in 
the presence of the cocktail of mitochondrial inhibitors. 340:365 fluorescence 
ratio changes corresponding to the changes in [Ca^^ were markedly different 
between the populations of cells loaded with each of the dyes.
4.4.2.1 Fura-2
Representative traces from experiments in the absence and presence of the 
mitochondrial inhibitor cocktail with Fura-2-AM loaded cardiomyocytes are 
shown in figures 4.7a and 4.7b. A representative graph from experiments 
carried out in the presence of mitochondrial inhibitors is shown in figure 4.5b.
In the presence of the mitochondrial inhibitor cocktail raising the cytosolic 
[Ca^ '*’] from <1nM to 760nM causes a rise in the 340:365nm fluorescence ratio. 
The rate and magnitude of this rise is very similar to that observed in the 
control experiment. As is the case with the other studies carried out in the 
presence and absence of A23187 (Figures 4.4a and 4.4b) thapsigargin 
addition has no apparent effect on the signal. Another striking similarity 
between these and the control experiments is that ionophore addition appears 
to speed up the rate of equilibration of Ca^ .^
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4.4.2.2 FuraFF
In FuraFF-AM loaded cells there is a significant difference between control 
experiments and those in the presence of mitochondrial inhibitors as shown in 
figures 4.8a and 4.8b. The most striking difference between the two sets of 
experiments are responses when [Ca^^] is raised, particularly the 0.38 and 
0.76^IVI additions. When mitochondria! inhibitors are present these ratio 
changes are very much smaller.
Comparing results obtained in the presence and absence of mitochondrial 
inhibitors, intriguingly, after increasing free [Ca "^"] to 0.76pM there is an initial 
rise in ratio followed by a decline, more pronounced in the control experiments. 
The reason for this Is unclear. Possibly the Ca^ "^  influx up into sub-cellular 
compartment(s) is proceeded by shuttling to other parts of the organelles or 
binding to Ca^ *" binding proteins.
In control experiments, but not those in the presence of mitochondrial 
inhibitors, thapsigargin addition causes a small decrease in the ratio. This 
would suggest that a small proportion of the signal can be attributed to SR 
Ca^ "^  dynamics, although the bulk of the FuraFF signal can be attributed to 
active mitochondrial Ca '^" uptake.
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4.4.2.3 Comparing the results with known buffered [Ca^*]
Figures 4.11a-4.11c shows the normalized fluorescence ratio values obtained 
with varying [Ca "^"] are shown for each of the three indicators. Data shown are 
from values obtained with the pentapotassium salt (free add, closed droles), 
AM loaded cardiomyocytes (open squares), AM loaded cardiomyocytes in the 
presence of mitochondrial inhibitors (open cirdes) and AM loaded 
cardiomyocytes in the presence of ionophore A23187 (closed diamonds). 
Examination of the Fura-2 data (Figure 4.11 a) reveals a deviation from the free 
add calibration under all of the experimental conditions with the AM loaded 
cells. The reason for this is undear. One possible explanation is that there is a 
shift in the indicator’s Kd for Ca '^" in that the Kd increases and thus the affinity 
decreases shifting the curve to the right (Harkins AB et a/., 1993).
Based on the calibration curves constructed for this thesis, the mean free 
[Ca^’*']M!T was estimated at approximately 3|.iM at [Ca^"']cYT= 760nM. This 
agrees well with estimates from adult cardiac myocytes using selective 
mitochondrial loading of lndo-1-AM (Griffiths, 2000) and mitochondria from 
other cell types using mitochondrially-targeted aequorin (Montero et ai, 2001) 
and (Montero et a i, 2000)
4.4.2.4 MgFura-2
In addition to FuraFF, experiments were carried out with cells loaded with 
MgFura-2-AM shown in figures 4.9a and 4.9b. Comparing the representative 
traces of control and presence of mitochondrial inhibitors does not reveal a 
significant difference in the ratio changes. This is in direct contrast with the
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experiments carried out with FuraFF-AM loaded cells where inhibition of active 
mitochondrial uptake significantly affects Ca^’*' influx into sub-cellular 
compartments.
Perhaps the most intriguing difference between FuraFF and Mg Fura-2 
experiments is the response to the addition of the ionophore A23187. in the 
presence of mitochondrial inhibitor cocktail, with FuraFF-AM loaded cells 
(figure 4.8b) A23187 addition apparently has no effect on the ratio, whereas 
with MgFura-2-AM loaded cells there is a rapid decline in the fluorescence 
ratio following ionophore addition. There is no significant difference in this 
change between control and experiments with mitochondrial inhibition. This 
presents somewhat of a puzzle as to why this happens as even with control 
experiments. The ratio decline following ionophore addition should appear to 
be smaller in magnitude with Mg Fura-2 as is the case following the Ca^^ 
additions due to the dye having lower Ca^"' affinity. The most probable 
explanation for this that the change observed with added A23187 is due to 
changes in [Mg^^] as Mg Fura-2 can also indicate Mg^ "^  changes and has been 
used in the past to monitor [Mg^T within organelles (Jung etal., 1996) (Jung et 
al., 1997).
The original aim of measurements with Mg Fura-2 was to measure free [Ca^ '^jsR 
within adult cardiac muscle. Previous studies using MgFura-2-AM loaded 
astrocytes and arterial myocytes have shown signals attributable to ER for 
astrocytes and SR for arterial myocytes (Golovina & Blaustein, 1997). Low 
affinity Fluo-based dyes have been used to estimate [Ca^ï within SR of
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smooth muscle (Shmigol et al., 2001) and skeletal muscle (Kabbara & Alien, 
2001). However as shown in the results, no signal could be obtained that was 
clearly attributable to the SR. The modelling described in the appendix to this 
chapter estimates the theoretical signal had MgFura-2-AM been loaded into 
the SR. A later chapter discusses why the SR Ca^^ signal does not appear to 
contribute to the Mg Fura-2 organelle signal.
4.4.3 Effect of changing the mitochondrial [Mg^T on the MgFura signal
As described previously, a somewhat intriguing result was observed when 
populations of cells were studied that had been loaded with MgFura-2-AM in 
the presence of mitochondrial inhibitors after addition of 1|iM A23187 (figure 
4.8b). This is indistinguishable from the control experiment (figure 4.8a). One 
possible explanation for this is that the observed rapid decline is due to a 
decrease in [Mg^"] within organelles containing Mg Fura-2. To investigate 
whether [Mg "^"] changes significantly within the cardiac myocyte; experiments 
were designed to specifically cause the free [Mg^^] to rise within organelles.
Nigericin and the respiratory substrate Succinate with Pi are known to increase 
[Mg "^"] of the mitochondrial matrix ([Mg '^"]m) (Brierly 1987, Jung & Brierly 1994). 
Representative diagrams are shown in figures 4.12 and 4.13. As expected the 
MgFura-2 ratio increases when both nigericin and succinate are added. This 
must be due to changes in ([Mg "^']m as Ca '^" is heavily buffered in this system 
with 5mM EGTA and the solution contains ImM Mg^ .^ In addition to this, a 
representative trace from experiments carried under the same conditions but
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with FuraFF-AM loaded ceils is shown in figure 4.16. This shows that addition 
of succinate with Pi causes virtually no change in ratio as is also the case with 
A23187 addition.
These results coupled with the knowledge that FuraFF is not magnesium 
sensitive, would suggest that there are substantial active accumulation of Mg^^ 
within the cardiac myocyte. The mechanism(s) and conditions under which this 
may occur are not well understood or characterised (Brierly 1987). A 
subsequent study of the changes occurring with [Ca^"] using the respiratory 
substrate succinate with added Pi was carried out, results of which are shown 
in figures 4.14 and 4.15. In addition to the MgFura-2-AM loaded cells, FuraFF- 
AM loaded cells were also studied. Availability of respiratory substrate such as 
succinate + Pi accelerate and increase Ca^^ influx into mitochondria.
4.4.4 Explanation of the results using a model
A semi-quantitative model is provided in an appendix to this chapter in an 
attempt to clarify these results. The model predicts that the Ca^^-sensitive 
signal in AM-loaded cardiomyocytes can be attributed predominantly to two 
compartments, one passive slowly exchanging compartment and an active 
compartment that is sensitive to mitochondrial inhibitors. The modelling 
predicts a significant thapsigargin sensitive Mg Fura-2 signal if significant 
amounts of the dye were able to load Into the SR. But the absence of this 
component from the measurements suggests that there is no significant SR 
component to the signal.
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Appendix to chapter 4
Semi-quantative compartmental model of 
permeabilised cardiac myocyte
(in collaboration with Godfrey Smith)
Cytosol
compartment
Ca^  Km2
Mitochondria
Value of rate constants:
Passive compartment: Kp1 = Kp2 = 0.01.
Mitochondrial compartment: Km1 = 10; Km2 = 1;
(+Mitochondrial inhibitors, Km1 = Km2 = 1).
SR compartment: Ksr1 = 2000; Ksr2 = 2; (+Thapsigargin, Ksr1 = Ksr2 = 2). 
All rate constants increased to 5.0 to simulate ionomycin treatment.
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Description o f the model:
in order to aid the interpretation of the fluorescence records from -AM  loaded 
permeabilised cardiac myocytes, a semi quantative model was constructed. 
Three compartments were used In the model:
(i) A passive, slowly exchanging compartment. The identity of this is 
unknown; exchange of Ca^ "" is Kp1=Kp2=0.01. This exchange time 
is speeded up by the addition of ionomycin (Kp1=Kp2=5)
(ii) Mitochondria; this compartment accumulates Ca^ "" to a value of 10x 
that within the cytosol. Addition of mitochondrial inhibitors is 
simulated by the reduction in the rate of uptake to the same value as 
leak (Km1=Km2=1). Addition of ionomycin is simulated by increasing 
rate constants (Km1 = Km2 = 5)
(iii) Sarcomplasmic reticulum (SR); this compartment accumulates Ca^ "" 
to a value of 100ÜX that within the cytosol. Addition of thapsigargin is 
simulated by the reduction of (Ksr1 =Ksr2=2).
Included in the calculations was the conversion of the Ca^^ signal within the 
compartment to ratio for the relevant form of Fura. The respective affinity 
constants used in the calculations were the values measured in free solution. 
The possibility that the affinity constant may be lower than that measured for 
the free acid is discussed later. The relative contribution of passive and 
mitochondrial compartments were equal. The model was initially run with no 
contribution by the SR, this was followed by calculation assuming that the Fura 
signal from the SR was 10% of that from mitochondria (red trace in Figure 2).
Time course and steady state Ca^* within the different compartments:
This model was used to simulate the experiments summarised in Figure 4.10. 
The model initially calculated the extent and time course of the changes of 
[Ca^^] within the 3 compartments in response to increasing the cytosolic [Ca '^ ]^ 
from <1nM to 760nM. The relative increase in the individual [Ca^T is shown in 
Figure 1. The steady state values of [Ca^^] in mitochondria and SR were based 
on previously published estimates (Shannon & Bers, 1997) & (Zhou etaL, 
1998).
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Figure 1. "Ame-course of [Ca *^l changes 
in different compartments
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The results shown in Figure 2 indicate that the model predicts the main 
features of the experimental results. In particular;
(a) The initially rapid, then gradual increase in the Fura-2 ratio can be 
explained by the Fura-2 signal reporting Ca^  ^from predominately two 
compartments; passive and mitochondrial. The rapid increase in Fura-2
ratio represents the active accumulation of Ca^ "" in the mitochondria to 
values that saturate the Fura-2. The subsequent slow increase is due to 
the slow accumulation of Ca^ *^  in a passive compartment, this 
equilibration process is speeded-up by the addition of inomycin.
(b) The Fura-2 signal in the presence of mitochondrial inhibitors represents 
the slow accumulation of Ca^ "" in two passive compartments namely the 
original compartment plus the now passive mitochondria. Hence the 
very large increase in ratio on addition of ionomycin. Note that the 
contribution from an SR component is predicted to be small.
(c) The Fura-FF signal is as observed in the experimental results. Note that 
the the addition of an SR compartment (grey line) mimics the small 
decrease in Fura-FF ratio seen in some preparation on addition of 
thapsigargin. However, the change in FuraFF ratio would be expected 
to be large when measured in the presence of mitochondrial inhibitors.
(d) The smallest changes in ratio were observed when simulating the use 
of MgFura. Note, modelling the SR contribution suggests that this 
indicator would be the best to discriminate the higher Ca^^ within this
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compartment (grey trace). The fact that no significant effect of 
thapsigargin was measured in practise indicates that the contribution of 
the SR to the MgFura signal is small.
This simple modelling supports the conclusion that -AM loaded 
cardiomyocytes contain predominately from two compartments, one passive 
slowly exchanging compartment and a second, active compartment, sensitive 
to mitochondrial inhibitors. There is no evidence of a significant signal from 
cardiac SR.
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Characteristics of the passive compartment
As described previously, the physical identity of the passive compartment is 
unknown. The main evidence for Its existence comes from the results 
recorded from Fura-2 loaded cardiomyocytes. The model descnbed earlier 
can be used to illustrate the differences in the predicted results if, instead of 
a compartment, calculations modelled simple Fura-2 binding (i.e. not rate 
constants affected by ionomycin). As shown in figure 3, the model would 
predict a decrease in Fura-2 ratio on addition of ionomycin. This results 
from a decrease in [Ca^T within an active compartment (mitochondria).
This decrease was not observed experimentally, instead the Fura-2 ratio 
increased, suggesting an increase in Fura-2 ratio due to rapid passive 
equilibration of Ca^ "^  . As discussed previously, options for this 
compartment include nucleus and/or non-functional mitochondria.
760nM Ca"
InM  Ca Ionomycin
11I Fura-2 signal0.4 -I —  Fura binding (no passive compartment)
—  Fura in passive compartment
0 ,2 -
0 .0 -
Time (arbitrary units)
Figure 3. Passive compartment vs Fura binding
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Chapter 5
Further studies of organelle calcium dynamics In
cardiac muscle
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c hapter 5-Further Studies Of Organefle Calcium Dynamics in 
Cardiac Muscle
5.1 Introduction
Results from chapter 4 suggest that the majority of the Fura-2 sensitive 
organelle signal arises from a passive exchange with organelles, while the 
majority of the FuraFF sensitive component is due to mitochondrial Ca "^' 
accumulation. This chapter describes experiments designed to address (i) the 
contribution of the SR Ca^  ^ signal to the total organelle signal and (ii) The 
ability of isolated SR and mitochondria to cleave AM derivatives of FURA dyes 
and prove a Ca^’^  sensitive indicator.
5.2 Methods
5.2.1 Oxalate driven SR Ca^* accumulation
Rabbit cardiac myocytes were enzymatically isolated as described in chapter 2 
general methods. Isolated cardio myocytes were loaded with FuraFF-AM as 
described in methods section, chapter 4. Cells were permeabilised by brief 
exposure to 0.01 mg/ml saponin and resuspended in a mock intracellular 
solution of the following composition: SOpM EGTA, lOOmM KOI, ImM MgCb, 
lOmM NaCI, 25mM HEPES, pH 7.0. Permeabilised ventricular myocytes were 
placed in a closed cuvette system, a description of which is given in the 
methods section of chapter 4. Measurements of the FuraFF fluorescence ratio 
(organelle) were made. The cytosolic (cuvette) [Ca^^] was simultaneously 
monitored with 1.3|aM Fluo-3 pentapotassium salt. It is possible to use these 
indicators simultaneously as their excitation wavelengths are sufficiently
1 0 6
different. A more detailed description of these indicators and their spectra is 
given in chapter 3.
Experiments were carried out in the presence of 10mM Oxalate to act as an 
agent to precipitate Ca^  ^ and to lower the intra-lumenal [Ca "^"] so as to drive 
active Ca^ "" uptake. The protocol involved addition of 2x SOnmol boluses of 
Ca^^ followed by thapsigargin. Following this was another SOnmoI bolus then 
the EGTA concentration was raised to 5mM to give a measure of Rmin. The 
cytosolic [Ca^''] was raised to 380nM by adding 5mM CaEGTA. Rmax was 
obtained on addition of 10mM CaCb. The experiments were carried out in the 
presence and absence of thapsigargin.
5.2.2 Studies of passive dynamics in cardiac muscle
In addition to the studies previously described in this chapter, experiments 
were carried out both in the absence and presence of ATP in order to study 
the characteristics of passive uptake.
Adult rabbit cardiac myocytes were prepared as described in the general 
methods section. Cells were loaded with 10|iM Fura-2-AM under the 
conditions described in chapter 4.
Aliquots of 2x 10® cells were then permeabilised by brief exposure to the agent 
saponin and the cells placed in a mock intracellular solution containing 50p.M 
EGTA, lOOmM KOI, ImM MgCb.lOmM NaCI & 25mM HEPES to mimic the 
cells’ intracellular environment. Experiments were carried out with and without
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the addition of SmM ATP and 15mM CrP to the mock intracellular solution. 
Cytosolic free [Ca^*] was monitored with the addition of 1.3fj.M Fluo-3.
For these studies the same closed cuvette system described in this chapter 
was used. The protocol involved the addition of 3x SOnmoI aliquots of CaCb at 
equally spaced time intervals. This was followed by the addition of 25)xM 
thapsigargin, SOnmoI CaCb, 5mM EGTA to obtain a value of the minimum 
fluorescence ratio value and finally SpM A23187 4-Bromo.
5.2.2.1 Studying Calcium Dynamics using confocai microscopy
Freshly isolated rat cardiac myocytes as described in general methods, were 
loaded with 20pM Fluo-3-AM in a 37°C incubator supplemented with 5% OO2 
on coverslips (thickness 1.S) pre-treated with 4pg/mL laminin for 1 hour. 
Calcium dynamics were studied in the cells using Biorad Radlence 2000 MP 
confocai microscopy system. Cells were perfused with the following buffered 
solutions at pH 7.0; (1) 10mM EGTA, (2) 10mM EGTA + 0.01mg/mL p-Escin, 
(3) 0.12|liM CaCb& (4) 0.38pM CaCb.
Parallel experiments were run using unloaded cells and solutions 1-4 above 
with added 10p.M Fluo-3 pentapotassium salt. Cells were visualized using 60x 
water objective lens and excited at 488nm with an Argon/Krypton laser (peak 
emission 488nm (5mW)) and the fluorescence detected using a 515±30nm 
band pass filter. Fluorescence and transmission images were captured. Sets 
of time series (each cycle 2s) were recorded using the Biorad software Laser
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sharp 2000 and the images obtained analysed using the Biorad software 
LaserPix.
5.2.3 Studies of dynamics in organelles isolated from cardiac 
muscle
In order to understand the observed results from studies of calcium dynamics 
of populations of cells, it was necessary to isolate organelles from cardiac 
tissue and to study the calcium dynamics in each individual fraction. 
Mitochondria and SR were isolated from rabbit heart and the resulting 
organelles used for subsequent study.
5.2.3.1 Preparation of Mitochondria from Cardiac tissue
White New Zealand male rabbits were subjected to deep anaesthesia with an 
intravenous injection of 500 U Heparin together with an overdose of Sodium 
Pentobarbitone (100mg/kg). The thoracic cavity was opened, the heart quickly 
excised and placed into a sterile beaker containing sterile, ice-cold Krebs’ 
solution (120mM NaCI, 20mM HEPES, 5.4Mm KOI, 0.52Mm NaH2P04, 3.5Mm 
MgCb.GHzO, 20mM Taurine, 10mM Creatine, 11.1mM Glucose, pH 7.4).
Atrial and fatty tissue were removed. The remaining tissue was transferred to 3 
volumes/g tissue of solution containing 0.3M Sucrose, 26mM HEPES pH 7.4 
and cut up into small pieces using scissors. The preparation was homogenized 
at 1,000 rpm keeping it as cold as possible. The homogenate was centrifuged 
at 500 X g at 4°C for 10 minutes.
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The nuclear pellet and supernatant were both retained. The supernatant was 
placed on ice. The pellet was re-suspended in 0.3M Sucrose, 25mM HEPES 
pH 7.4 and re-homogenized for 1 minute. This was centrifuged again at 500 x 
g at 4°C for 10 minutes. After this step the pellet was discarded. Supernatant 
from both the 500 x g spins were pooled and placed on Ice. The aim of pooling 
the supernatants is to increase the yield of mitochondria in the subsequent 
step. The pooled supernatants were centrifuged at 10,000 x g at 4°C for 15 
minutes.
The mitochondrial pellet was re-suspended in a solution containing 0.4M 
sucrose and 4.2mM HEPES pH 7.2. Mitochondria were either used for studies 
immediately prior to preparation or stored at -80°C until use. Prior to use, a 
small aliquot of the preparation was retained and placed on ice in order to 
ascertain the protein concentration present.
5.2.3 2 Preparation of SR vesicles from Cardiac tissue
Rabbit heart ventricular tissue was obtained in the same manner as described 
for preparation of the mitochondria. Tissue was placed in 3 volumes/g tissue of 
solution containing 0.3M Sucrose, 25mM HEPES pH 7.4 and cut up into small 
pieces using scissors. The preparation was homogenized at 1,000 rpm 
keeping it as cold as possible. The homogenate was then centrifuged at 
6,500g for 20 minutes at 4°C. The supernatants from this step were transferred 
to fresh centrifuge tubes and centrifuged at 100,000g for 35 minutes at 4°C. 
During this 35 minute period discontinuous sucrose gradients were poured by
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carefully layering 2ml of 10%, 20%, 30% and 40% sucrose solutions in 
ascending order of the sucrose concentration, so therefore the solution with 
the greatest density first. Sucrose solutions were prepared by addition of the 
appropriate mass of sucrose in a solution containing 2M KCI, 0.5M EGTA, 
30mM HEPES, 0.5mM MgCb and O.SmM CaCb. The pellets from the 
100,000g spin were resuspended In 10% sucrose solution and 1ml of 
homogenate carefully layered onto each sucrose gradient. The purpose of this 
step is to further purify the crude SR prep into the heavy SR vesicle (HSR) 
fraction. This is obtained at a higher density containing terminal cisternae, the 
ryanodine receptors and the Ca pumps (SERCA).
The band corresponding to the HSR on the 30%/40% interface of the gradient 
was removed and the sucrose concentration lowered on addition of 0.4M KCI. 
The HSR was then centrifuged at 100,000g for 35 minutes at 4°C. The 
resulting pellet was resuspended in a solution containing 0,4M Sucrose and 
5mM HEPES. A small aliquot of the preparation was retained and placed on 
ice in order to ascertain the protein concentration present. The remaining 
preparation was flash frozen in liquid Nitrogen and stored at -80°C.
5.2.4 Determination of totai protein concentration present
The method is a modification of the Bradford protein assay. Protein content 
(mg ml'^) was determined using the Coomassie Plus protein reagent (Pierce). 
Protein standards were prepared using MilliQ grade water and Bovine serum 
albumin (BSA) at concentrations of 0.1-1 mg m f\
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Prepared mitochondria and HSR samples were diluted in MilliQ grade water 
1in 10, lin  20 and 1 in 50. Both the standards and the diluted samples were 
assayed in triplicate on a 96 well plate. lO^iL of each sample or standard was 
placed in each well. To each well was added 200pL of Coomassie reagent. 
Protein content was determined by measuring the absorbance of the samples 
at 595nm. The BSA standards were used to construct a calibration curve and 
from this the protein content of the preparations ascertained. A typical 
calibration fitted to a sigmoidal curve is shown in figure 5.1.
Figure 5.1. Protein calibration curve using BSA standards and coomassie 
plus reagent.
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5.2.5 Studying the calcium dynamics in isolated HSR & Mitochondria
It was necessary to first optimise the concentration of HSR and mitochondria 
used in each experiment so as to demonstrate that there was measurable Ca^’*' 
uptake activity. Varying concentrations of HSR were used to demonstrate 
oxalate-driven Ca^ .^ The appropriate volume of HSR was placed in a cuvette 
containing 10jaM Fura-2 pentapotassium salt and a mock intracellular solution 
of the following composition: SOjiiM EGTA, lOOmM KCI, 1mM MgCb.lOmM 
NaCI, 25mM HEPES, 5mM ATP and 10mM CrP. The studies were performed 
using the cuvette system descnbed in the methods section earlier in this 
chapter using excitation wavelengths for Fura-2 of 340 and 365nm.
Experiments were carried out in the presence of 1DmM oxalate and involved 
the addition of 2x SOnmoI Ca^^ boluses, thapsigargin addition and finally an 
additional SOnmoI Ca^ "^  bolus. An estimation of Fura-2 Rmin was obtained by 
raising the EGTA concentration to SmM and Rmax estimated on addition of 
1S i^L 1M CaCb solution.
The optimum concentration of HSR and mitochondria (SOO^g) was used and 
an attempt was made to load the organelles with FuraFF-AM. HSR were 
placed in the above mock intracellular solution containing 1mM EGTA with 
lOfiM FuraFF-AM. The samples were placed at 4°C for 1 hour and a duplicate 
aliquot placed at room temperature. The aim of these experiments was to 
simulate experiments carried out within the whole cell populations. The 
protocol involved using SOO^g of HSR/mitochondria per preparation in a mock
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intracellular solution of the following composition: 5mM EGTA, 25mM HEPES, 
6.5mM MgCb, lOmlVI KCI, 5mM ATP and 10mM CrP. The cuvette free [Ca^^] 
representative of the cytosolic free [Ca *^"] in the cell populations described 
earlier in this chapter, was raised to 760nM using CaEGTA solution. This was 
followed by addition of 26^M thapsigargin and then 1 juM of A23187-4-bromo.
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5,3 Results
6.3.1 Oxalate driven SR Ca^* accumulation
Representative traces showing the simultaneous measurement of the FuraFF 
(organelle) and Fluo-3 (cytosolic) signals is shown in figure 5.2.
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Figure 5.2. Oxalate driven Ca^* uptake with FuraFF-AM loaded 
cardiomyocytes.
The grey trace depicts the FuraFF ratio and the black trace the cytosolic [Ca^^] 
ascertained using Fluo-3 pentapotassium salt. Arrows indicate addition of 
SOnmoI Ca^^. [Ca^^] decreased to <1nM on addition of 6mM EGTA and 
increased to 380nM on addition of SmM CaEGTA.
Addition of the initial SOnmoI bolus of Ca^ "^  causes an increase in the FuraFF 
ratio (grey trace) implying an increase in the [Ca "^"] within a sub-cellular 
compartment or compartments. A subsequent SOnmoI addition causes a 
further increase in the FuraFF ratio. In parallel, the cytosolic [Ca^^] indicated by
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the Flu0-3 signai (black trace) Initially rises and then declines. Addition of 
25|il\/l thapslgargin causes a small decrease in 340;366nm ratio and a small 
increase In the fluo-3 signal. An additional 50nmol bolus does not cause an 
increase in the FuraFF ratio and the cytosolic [Ca^^] increases and does not 
change.
Figure 5.3 shows representative traces from experiments carried out in the 
presence of 25|j,M thapslgargin. Addition of 2x 50nmol Ca^^ boluses causes an 
increase in the FuraFF ratio. The Fluo-3 signal also increases but does not
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Figure 5.3. Oxalate driven Ca^* uptake with FuraFF-AM loaded 
cardiomyocytes in the presence of 26pM thapslgargin.
The grey trace depicts the FuraFF ratio and the black trace the cytosolic [Ca^ '*‘] 
ascertained using Fluo-3 pentapotassium salt. Arrows indicate addition of 
SOnmol Ca^T
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Table 5.1 shows the mean changes In FuraFF ratio per second (AFuraFF) and 
the mean rate of Ca^^ uptake. Measurements made in the presence and 
absence of 25p.M thapslgargin.
AFuraFF ratio Rate of Ca^* uptake nM s'""
Control 0.567 + 0.031 n=3 22.3 + 5.1 n=7
25^M thapslgargin 0.568 + 0.033 n=3 0.032 + 0.02 n=6
Table 5.1. Mean Ca^* transport rates of subcellular compartments and 
cytoplasm in the presence and absence of 25p,M thapslgargin.
Change in FuraFF ratio per second and rate of Ca^  ^uptake in FuraFF-AM 
loaded cardiac myocytes in a mock intracellular solution containing 50|iM 
EGTA.
5.3.2 Calcium dynamics with low buffering
Experiments were carried out both in the presence and absence of 5mM 
ATP/15mMCrP.
In the absence of ATP, shown in figure 6.4, on addition of SOnmol aliquots of 
Ca^ "^  there is a decline in fluo-3 fluorescence and rise in Fura-2 ratio. However 
the rate of the apparent Ca^ '*' influx into a sub-cellular compartment is slow. 
Thapslgargin addition caused an increase in the Fura-2 ratio, accompanied by 
a decline in Fluo-3 fluorescence.
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Figure 5.4. Fura-2-AM loaded cardiomyocytes.
Shows the changes in fluo-3 fluorescence and fura-2 ratio in response to the 
addition of SOnmol Ca^”" before and after the addition of a compound to block 
active uptake of Ca^”^ into an intracellular store. Fluo-3 fluorescence is shown 
in black and indicates the external [Ca^ "^ ]. Fura-2 ratio is shown in grey 
indicates [Ca^^] within sub-cellular compartments.
The mean change in [Ca "^"] under these conditions is 5.3+1.15 nM s“^  (n=13) 
that corresponds to approximately 300nM min“^
5.3.3 Single cell studies
A number of Fluo-3-AM loaded cells were perfused with different solutions and 
studied using confocal microscopy. Fluorescence changes due to excitation at 
488nm of a representative cell are shown in figure 5.5. Addition of the 
permeabilising agent p-escin caused a rapid decline in fluo-3 fluorescence
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indicating that the majority of cleaved fIuo-3~AM free in the myoplasm is 
leaving, in theory, the remaining cell fluorescence is due mainly to indicator 
trapped within organelles/bound to cellular structures.
Addition of 0.38pM free Ca^"” caused a rise in fluorescence with 2 components; 
an initial rapid rise followed by a secondary slower rise. Subsequent addition of 
10mM EGTA caused a decline in fluorescence.
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Figure 5.5. Representative Fiuo-3-AM loaded cell.
Shows the changes in fluorescence after permeabilisation with 0.1 mg/mL p- 
escin followed by an increase in the free [Ca "^"] to 0.38|j,M and then decreasing 
the free [Ca^’^ j to <1 nM.
Parallel experiments were carried out using unloaded cells. A representative 
fluorescence trace is shown in figure 5.6.
After permeabilisation with 0.1 mg/mL p-escin, the cells were perfused with the 
same perfusates as used with the fluo-3-AM loaded cells with added Fluo-3 
add. Higher fluorescence within the cell indicates significant fluo-3 binding.
p-Escin
<1nM Ca""
100s
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increasing Ca^^ to 0.38fiM causes an increase in fluo-3 fluorescence without a 
subsequent secondary slow rise.
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Figure 6.6. Fluo-3 acid loaded single cell study.
Representative unloaded cell permeabilised with p-escin with 10pM Fluo-3 
acid in the extracellular solution. Fluorescence monitored from the cell and the 
background (extra-cellular solution)
5.3.4 Calcium dynamics in isolated organelles
Mitochondria and SR were isolated from rabbit heart and the resulting 
organeiies used for subsequent study.
6.3.4.1 Studies with isolated SR
The concentration of prepared HSR was determined using the modified 
version of the Bradford protein assay. The optimum amount of HSR used per 
experiment was ascertained as being SOOpg. Figure 5.7 demonstrates a typical
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trace from an experiment following the oxalate driven Ca^ "^  uptake 
characteristics of HSR.
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Figure 5.7. dynamics of HSR.
HSR in solution containing 50pM EGTA, 10mM oxalate and 10|iM Fura-2 
pentapotassium salt. Ca^" additions indicated on the diagram by arrows.
Addition of the first two SOnmol Ca^ *" boluses causes an increase in the Fura-2 
340nm;365nm fluorescence ratio followed by a decline. The fluorescence ratio 
increased by a small amount following thapsigargin addition. A final SOnmol 
Ca^* bolus caused a sustained rise in the Fura-2 fluorescence ratio. Figure S.8 
shows a representative trace from experiments carried out with HSR incubated 
with 10|.iM FuraFF-AM. The graph shown is representative of experiments 
carried out in a mock intraceilular solution containing SmM EGTA. The protocol
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shown here simply involved raising the cuvette free [Ca^^] to 760nM and 
addition of 15^11M CaCb solution in order to obtain an estimate of Rmax.
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Figure 5.8. FuraFF fluorescence ratio recorded from SOOjig HSR 
Incubated with FuraFF-AM.
Extra-SR [Ca^^] increased to 760nM followed by an increase to 10mM Ca^ "^ .
Raising the extra- SR [Ca^”^ ] from <1 nM to 760nM does not cause any change 
in the FuraFF fluorescence ratio. A similar study was carried out with a 
modified protocol to that above. A representative graph is shown in figure 5.9.
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Figure 5.9. A study In the presence of 5-1 SmM EGTA. HSR Incubated with 
FuraFF-AM.
In this subsequent study, a representative trace shown in figure 5.9, again the 
cuvette free [Ca^’*'] was raised from <1nM to 760nM. This causes a very small 
hardly detectable rise in the 340:365nm fluorescence ratio. Following 
thapsigargin and ionophore additions, again there appears to be virtually no 
change in the ratio.
S.3.4.2 Studies with Isolated mitochondria
Figures 5.10-12 show representative graphs from experiments carried out with 
isolated mitochondria loaded with Fura-2-AM in the absence and presence of 
A23187 and a cocktail of mitochondrial inhibitors. The protocol was a repeat of
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that used for the cell population experiments. The concentration of 
mitochondria required to give a measurable fluorescence signal was optimised 
and found to be 250pg. Mitochondria were suspended in the same mock 
intracellular solution as used for the cell experiments containing 5mM EGTA. 
The study involved raising the extra-mitochondrial [Ca "^"] from <1nM to 760nM. 
This was followed by thapsigargin addition, then ionophore. Rmax was 
ascertained by raising the [Ca "^"] to 10mM. Under all 3 experimental conditions, 
raising extra-mitochondrial [Ca^^ to 760nM causes an increase in the 
340:365nm fluorescence ratio. Subsequent thapsigargin and ionophore 
addition has no effect on the ratio.
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Figure 5.10. 500p,g Fura-2-AM loaded mitochondria In the presence of 5- 
15mM EGTA.
Extra-mitochondrial [Ca '^*'] was raised to 760nM followed by thapsigargin 
addition and finally increasing the [Ca^"] to lOmM.
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Figure 5.11. 500^.g Fura-2-AM loaded mitochondria in the presence of 5- 
15mM EGTA and I^M Oligomycin, 2|iM CCCP and IjnM rotenone.
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Figure 5.12.. 500^g Fura-2-AM loaded mitochondria in the presence of 5
15mM EGTA and 1 | j lM  A23187.
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Figures 5.13-15 are representative graphs from studies with isolated 
mitochondria loaded with FuraFF-AM. Mitochondrial Ca^"' dynamics was 
studied in the absence and presence of mitochondrial inhibitors and ionophore 
using the same protocol as that used for the Fura-2-AM experiments. In the 
control experiments, raising extra-mitochondrial [Ca^ "^ ] to 760nM causes a 
small rise in the 340;365nm fluorescence ratio. Thapsigargin addition also 
causes a very small increase in the ratio. A23187 addition causes a small 
decrease in the fluorescence ratio. In the presence of the mitochondrial 
inhibitor cocktail, again increasing the [Ca^*] to 760nM causes a small Increase 
in the 340:365nm fluorescence ratio. In the studies in the presence of A23187, 
initial ionophore addition causes a decrease in the ratio. Raising the extra- 
mitochondrial [Ca^ "*"] from <1nM to 760nM causes an increase in the 
340:365nm fluorescence ratio. Thapsigargin addition causes no change in the 
fluorescence ratio.
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Figure 5.13. 500^g FuraFF-AM loaded mitochondria in the presence of 5- 
ISmM EGTA.
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Figure 5.14 500^g FuraFF-AM loaded mitochondria in the presence of 5- 
15mM EGTA and 1|iM Oligomycin, 2pM CCCP and 1|j,M rotenone.
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Figure 5.15. 500pg FuraFF-AM ioaded mitochondria in the presence of 5- 
15mM EGTA and IpiM A23187
5.3.4.3 Comparing the responses of isolated cardiac myocytes and 
isolated mitochondria
Figure 5.16 shows the mean normalized ratio for isolated cardiac myocytes 
and mitochondria loaded with Fura-2-AM and FuraFF-AM in the presence and 
absence of the mitochondrial inhibitor cocktail (1p.M oligomycin, 3pM CCCP 
and 1 |iM rotenone)
Response of cardiac cells and iritochondra loaded with FURA 
based indicators to [Caf*]j,^=760nWI
Fura-2-AIVI
mitochondria
control +m ito inhib
FuraFF-AM
C 3  cells
control +mito inhib
Figure 5.16. Comparison of response of mitochondria and 
cardiomyocytes loaded with Fura-2-AM & FuraFF-AM to [Ca^^cYT=760nM
* Indicates that this data is significantly different (p<0.01)
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The ratio is normalized to Rmin and Rmax and measured at [Ca ’^"]cYr=760nM.
For Fura-2-AM loaded preparations, for both cells and mitochondria the 
presence of mitochondrial inhibitors does not significantly alter the mean 
normalized ratio. This is the case for both the mitochondria and cell 
preparations. However, with FuraFF-AM loaded cell preparations the mean 
normalized FURA ratio is substantially smaller in the presence of mitochondrial 
inhibitors compared to the control. The response of the mitochondria loaded 
with FuraFF-AM to the 760nM Ca^^ challenge is a great deal smaller than of 
the FuraFF-AM loaded cells.
S.3.4.4 Comparing efficiency of loading of FuraFF-AM into isolated ceils, 
mitochondria and HSR
The efficiency of loading of FuraFF-AM was compared for cells, mitochondria 
and HSR. Data is expressed as Rmax-Rmin. The mean values for cells, 
mitochondria and HSR are shown in figure 6.17. The highest Rmax-Rmin mean 
value is for the cells, followed by mitochondria and the lowest is for HSR.
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Figure 6.17. Comparison of the loading efficiency of FuraFF-AM
* denotes p<0.05, ** p<0.001.
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5.4 Discussion
5.4.1 is there a thapsigargin sensitive component to the FuraFF signai?
The mean data for the change in FuraFF ratio (AFuraFF) shown in table 5.1 
indicate that within our cell preparations there is an active SR indicated by the 
changes in the Fluo-3 signal. Comparing the FuraFF traces from studies in the 
presence and absence of thapsigargin, there does not appear to be a 
significant difference between them further suggesting that SR does not 
contribute significantly to the organelle based FuraFF signal. This is consistent 
with the results from chapter 4. The reason for the absence of significant 
FuraFF-AM loading of the SR is unknown. Previous work on other muscle 
preparations have demonstrated a signal from low affinity indicators that was 
thought to originate from the SR (Golovina & Blaustein, 1997) and (Shmigol et 
al., 2001)
6.4.2 Studying passive equilibration
5.4.2.1 Ca^* accumulation in low buffering
Following the results of chapter 4 where a passive equilibration of Ca^^ was 
revealed, it was decided to study this further. Experiments were carried out in 
the absence of. A representative trace from such experiments with Fura-2-AM 
loaded cardiomyocytes using Fluo-3 as an indicator of the cytosolic [Ca^”^] and 
50pM EGTA, is shown in figure 5.4. Addition of 3 x SOnmol Ca^^ boluses in 
each instance causes a rise in the fluo-3 fluorescence followed by a decline, 
however the rate of decline following the second and third additions is slower. 
The mean rate of rise corresponds to 5.3+ 1.15nM s"'' (n=13) in the absence of
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ATP. Interestingly, thapsigargin addition appears to speed up the rate of 
equilibration of Ca^ '*' in the intracellular shown by the red Fura-2 ratio, albeit a 
small effect. This is also apparent in studies using Fura-2-AM cardiomyocytes 
in the presence and absence of ionophore A23187. Representative diagrams 
from these experiments are shown in chapter 4, figures 4.4a and 4.4b. The 
reason for this result is unclear. One possibility is a non-specific effect on 
cellular membranes of the substance DMSO used as a solvent for 
thapsigargin.
The cellular origin of the slow-exchanging compartment is unknown. As 
discussed in chapter 4, one possibility is passive exchange across the 
mitochondrial membrane. Previous studies of Ca^’" exchanging compartments 
have identified this as the slowest exchanging compartment (Langer et al., 
1990)
5.4.2 2 Single celi studies
Parallel experiments were carried out with Fluo3-AM loaded cells using 
confocal microscopy. A representative graph is shown in figure 5.5. Addition of 
the permeablising agent p-escin causes a rapid decline in the cellular 
fluorescence although a significant level of fluorescence remains. Raising the 
cytosolic [Ca^^] to 380nM results in a rise in the fluo-3 fluorescence. This rise 
consists of 2 components: an initial rapid rise followed by a secondary slower 
rise. Lowering the cytosolic [Ca^""] to <1nM by perfusing the cell with a solution 
containing iOmM EGTA causes a decline in the fluo-3 fluorescence. This is 
due to buffering of the Ca^^ within the system and could be attributed to 
apparent passive unloading of sub-cellular compartment(s) as the [Ca "^"]
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becomes altered when the cytosolic [Ca^’*'] becomes heavily buffered and very 
much lower.
In addition to these studies, experiments were carried out using unloaded 
cells. A representative fluorescence trace is shown in figure 5.6.
After permeabilisation with p-escin, the cells were perfused with the same 
perfusates as used with the fluo-3-AM loaded ceils with added 10|aM Fluo-3 
acid. The background and cellular fluorescence are shown. The higher 
fluorescence within the cell indicates significant fluo-3 binding. Increasing Ca^ '*' 
to 0.38|liM causes an increase in fluo-3 fluorescence without a subsequent 
secondary slow rise. The rise in the fluorescence does not show a biphasic 
response, as is the case with the FIuo-3-AM loaded cardiomyocytes.
These results from the single cell confirm that the results observed with the 
multi-cellular preparations are valid. Thus it is unlikely that the slow 
components of Ca^’*' exchange seen in the multi-cellular preparations are the 
result of a fraction of the cell population remaining unpermeabillsed after 
saponin exposure.
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5.4,3 Ca^* dynamics in isolated organelles
5.4.3.1 Ca^  ^dynamics in HSR
The viability of the HSR fraction was determined by measuring the rate of Ca^ "" 
uptake. On addition of a bolus of Ca^ "^  using 500pg HSR protein, thapsigargin 
sensitive Ca^ "" uptake was easily measured. Using this concentration of HSR, 
attempts were made to load fluorescent indicator (FuraFF) via incubation with 
the AM derivative. The extent of FuraFF-AM loading was assessed by 
examining the change in fluorescence ratio in switching from low to high Ca^ .^ 
As shown for the mean values (figure 5.17), there appeared to be negligible 
loading of the indicator compared to cells or isolated mitochondria. Previous 
researchers have obtained signals from SR vesicles by incorporating free add 
derivatives of the Ca^^ indicators during the differential centrifugation steps 
(Saiki & Ikemoto, 1997) and (Shannon & Bers, 1997)
It is dear from this result that either there is no Ca^'’ sensitivity of the AM 
loaded FuraFF or there is no uptake of Ca^ "^  by the preparation. It is most likely 
to be the former rather than the latter as examination of figure 5.7 shows the 
preparation to be viable, demonstrated by the ability to actively sequester 
Ca "^'. A similar study was carried out with a modified protocol. In this 
subsequent study, a representative trace shown in figure 5.9, again the cuvette 
free [Ca^ "^ ] was raised from <1nM to 760nM. This causes a very small hardly 
detectable rise in the 340;365nm fluorescence ratio. Following thapsigargin 
and ionophore additions, again there appears to be virtually no change in the
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ratio. Addition of 15^L 1M CaCb does result in a significant increase in the 
fluorescence ratio, albeit a great deal smaller than one would expect.
Taking all of the results from figures 5.7-9, I conclude that this method of 
preparation of HSR generates a preparation that is viable and behaves as a 
representation of the native SR present in the whole cell. It does not appear to 
be possible to use FuraFF-AM as an indicator to monitor the intra-lumenal 
[Ca^T within the HSR of cardiac muscle. One possible explanation is that the 
esterases present with SR are for some reason relatively inactive or possibly 
not present in the same proportion as in other sub cellular compartments. 
Another possibility is that the efficiency of loading of FuraFF-AM is poor as 
indicated in figure 5.17, where the loading efficiency of cells, isolated 
mitochondria and HSR is compared. Since HSR has the lowest Rmax-Rmin 
value, this would indicate that HSR have the lowest FuraFF-AM loading 
efficiency and could provide an explanation for the results observed.
This technique was tried several times during this study, but no significant dye 
loading was obtained. The conclusion from this work is that SR vesicles do not 
contain significant amounts of active esterase. This would suggest that 
previous studies obtain fluorescence indicator loading because (1) Intact SR 
contains active esterase and (2) Cleaving of the indicator occurs elsewhere in 
intact cells and the active indicator is shuttled to the SR. This latter explanation 
may be compatible with the observations in non-muscle cells (Mogami H etal., 
1998) (Mogami H etal., 1999)
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Here ER-loading with fluorescent dyes is routine, therefore in some muscle 
cells ER and SR may be linked and allow equilibration of the dye.
5.4.3 2 Studies with isoiated mitochondria
The results from these FuraFF studies again show a small component of the 
signal being attributed to passive equilibration. However the magnitude of this 
is far smaller than that observed with the mitochondria loaded with Fura-2-AM. 
However the active component of this signal is smaller than that observed with 
the whole cell. This is demonstrated In figure 5.16 where the responses of 
Fura-2-AM and FuraFF-AM loaded mitochondria and cells to 760nM Ca^* 
challenge are compared in the presence and absence of mitochondrial 
inhibitors. The magnitude of the response of FuraFF-AM loaded mitochondria 
to the challenge is substantially smaller shown by the reduction in the FuraFF 
ratio. Indeed statistical analysis using the student’s t-test indicates that the 
difference is significant. One possible explanation for this is the fact that we 
may be dealing with a large proportion of damaged mitochondria within the 
preparation. This could render the mitochondria apparently less sensitive to 
Ca^^ due to damaged mitochondrial membrane proteins involved in 
sequestering Ca^ "^  such as the uniporter. The susceptibility of cardiac 
mitochondria to damage has been previously reported in terms of a variable 
activity of the uniporter (Buntinas etal., 2001).
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Chapter 6
Calcium Dynamics Within The SR Of Cardiac 
Muscle Using A Targeted Probe
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Chapter 6- Specific Studies Of SR Calcium Dynamics Using An 
Aequorin Based Probe
6.1 Introduction
Previously I have demonstrated that it is not possible to monitor Ca^^ dynamics 
specifically within SR in cardiac muscle using the commercially available 
FURA-based Ca^ "" indicators. The majority of the signal from -AM loaded cells 
could be attributed to mitochondria with no clear contribution from SR.
For this reason I considered the generation of a Ca^ "^  indicator specifically 
targeted to the SR, namely Aequorin. Aequorin is a photo-protein and was 
originally isolated from the jellyfish Aequorea Victoria. The aequorin complex 
comprises a 22,000-dalton apoaequorin protein, molecular oxygen and the 
luminophore coelenterazine. When three Ca^  ^ ions bind to this complex, 
coelenterazine is oxidized to coelenteramide, which results in release of 
carbon dioxide and blue light, the intensity of which is proportional to [Ca^"'].
This indicator's usefulness was limited by the need to microinject the protein 
into living cells making fluorescent dyes the method of choice for measuring 
intracellular [Ca^"j. The complete aequorin cDNA has cloned and sequenced 
(Inouye et al., 1985). This has expanded the possible uses of this 
photoprotein.
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Development of aequorin specifically targeted to sub-cellular locations has 
permitted the measurement of [Ca^"] within organelles (Brini M et al., 1995), 
(Robert etal., 1998) & (Brini M etal., 1997).
Targeting of a protein-based indicator molecule is achieved by fusing the 
cDNA of the indicator to the cDNA of a protein native to the particular sub- 
cellular compartment or a targeting sequence that causes its localisation to the 
compartment. The resulting is then endowed with a defined intracellular 
location. A simplified scheme of this targeting within the cell is shown in figure 
6 .1.
Signal sequence Aequorin
I I cDNATranscription NUCLEUS
iTranslation
mRNA
CYTOSOL
Chimaeric 
Protein
LFolding & sorting of protein to a specific intracellular location
Figure 6.1 Simplified scheme for targeting of aequorin to a specific 
intracellular location.
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However, the major drawback of targeted aequorin is that the bioluminescent 
signal is rather weak. Therefore the signal has to be recorded from populations 
of cells rather than single cells.
In order to monitor Ca^^ dynamics within cells that have been transfected with 
apoaequorin cDNA, it is first necessary to reconstitute the bioluminescent 
aequorin complex with coelenterazine. Several synthetic analogues of 
coelenterazine exist that confer different Ca^^ affinities and spectral properties 
on the aequorin complex. The coelenterazine analogue we used in our studies 
was coelenterazine n as it decreases the Ca^  ^ sensitivity of the reconstituted 
complex to values appropriate for measurement of [Ca^ '^jsR.
6.1.1 SR targeted Aequorin
A mutated aequorin chimera has been previously used to measure free SR 
[Ca '^"] in cultured myotubes. The Ca^ "^  affinity was reduced in this aequorin 
mutant by an amino acid change of Aspartate-119 to Alanine (Asp-119^Ala) 
in the Ca^  ^ binding sites. The Ca^^ affinity was further reduced using a 
modified prosthetic group, Coelenterazine n.
Targeting of the photoprotein was achieved by generation of a construct that 
consisted of cDNA encoding the SR resident protein calsequestrin fused to the 
aequorin cDNA (p srAEQ) (Brini M et al., 1997). The construct also contains a 
HA1 tag containing 9 amino acids, which is derived from Haemagglutinin A. 
The purpose of this tag is to enable immunocytochemical localisation of the
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expressed protein. Aequorin itself is a poor immunogen and thus effective 
antibodies are not available (Chiesa et al., 2001). A simplified diagram of the 
construct is shown in figure 6
CSQ HA1 mutAEQ
Figure 6.2. CSQ-AEQ chimera.
An adenovirus was generated from the aequorin-calsequestrin plasmid (Ad 
srAEQ).
6.1.2 Adenovirus mediated gene transfer
Classic transfection methods such as the use of commercially available 
transfection reagents, electroporation or Calcium Phosphate assisted 
transfection are limited by their poor efficiency in terminally differentiated cells 
such as cardiac myocytes. The method of choice when working with such cells 
is adenoviral mediated gene transfer. Recombinant Adenoviruses have been 
used to over-express particular proteins both in vivo and in vitro both in cells in 
culture and whole organs (Kohout etal., 1996), (Villarreal et a!., 1996), (Baudet 
et al., 2001), (Westfall et al., 1997), (Miyamoto et al., 2000) & (Donahue et al., 
1997)
Adenoviruses are a group of double-stranded DNA viruses that infect a variety 
of vertebrate hosts (Horwitz, M.S., 1996). More than 40 serotypes and 93 
different varieties of adenovirus have been identified to date. Serotype 5 has
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been the most widely used in the quest to produce viral expression vectors as 
they have been extensively characterised and the genome sequenced.
6.1.2.1 Structure of Adenovirus
Adenovirus consists of an icosahedral protein capsid 70-100 nm in diameter. 
Inside the capsid resides the double stranded DNA genome. The main 
features of Serotype 5 are shown in figure 6.1.
Knob Domain
Hexon
Linear Genomic DNA
Penton Base 
Core Protein
Figure 6.3. Adenovirus type 5.
Main structural and molecular features.
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Conveniently, the complete 35,936 bp sequence of type 5 has been 
elucidated.
The genome is divided up into 100 equally spaced map units. There are nine 
major transcription units divided into early (E1-E4) and late (L1-L5).
Upon initial infection of the cell, the E1A protein is produced from transcripts 
in the E l region. E l A is required for transcription of all of the other early 
transcripts. In replication deficient viral vectors the El region is deleted.
The first step in the development of adenoviral vectors occurred with the 
generation of transformed Hamster Embryonic Kidney cells (Graham et al., 
1977).
The cells were transformed by exposing them to sheared fragments of 
adenovirus type 5 DNA. This transformation gave rise to the HEK 293 cell line. 
HEK 293 cells contain the left 14% of the 5’ end of the adenovirus genome 
integrated into cellular DNA including the E l region (Becker et al., 1994).
Adenoviral mediated gene transfer offers many advantages when used with 
cells such as cardiac myocytes. These include:
1. Broad host Range: Adenoviruses can infect a broad range of mammalian 
cells and permit expression of recombinant proteins in most mammalian cell 
lines and tissues.
2. High expression levels: High levels of exogenous protein expression 
even in terminally differentiated cells.
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3. Cell viability; Cells tolerate infection and remain viable to perform 
functional studies (Graham etal., 1977).
4. High Infectivity: Cells in culture are infected with almost 100% efficiency.
5. Ease of production; It is relatively easy to propagate virus in high titres.
Although there seem to be a great deal of advantages in using this system, 
there are however several drawbacks, it has indeed been demonstrated that 
using adenoviral transfer vectors can achieve high expression of the transgene 
in many target organs. In vivo expression of the transgene is limited in time 
due to a complex combination of innate and adaptive immune host defences 
against the virus (Hackett, 2000).
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6.2 Methods
6.2.1 Generation of AdCSQ-Aeq
This follows the method of Becker et al. (1994).
6.2.1.1 Subcloning of CSQ-Aeq into the vector pACCMV.pLpA
The construct containing the aequorin chimera (pCSQ-Aeq) was a kind gift 
from Dr. Rosario Rizzuto (Ferrara, Italy), pCSQ-Aeq and the vector 
pACCMV.pLpA were subjected to restriction digestion with EcoR\ and HlndWl. 
The plasmid pACCMV.pLpA is a shuttle vector. The plasmid contains a 
Cytomegalovirus (CMV) early promoter to drive transcription of the cDNA of 
interest with a cloning cassette downstream. In addition there are fragments of 
adenovirus type-5 genome that allows the subsequent generation of the 
infectious adenovirus. The presence of these sequences does not affect 
construct function.
Linearisation of the pACCMV.pLpA vector was confirmed by subjecting a 
small aliquot to agarose gel electrophoresis (1% agarose, TBE, ethidium 
bromide) and visualising using UV light. A ligation reaction was set up using 
Fast-Link™ DNA ligation kit (Epicentre technologies). Manufacturer’s 
instructions were followed.
After this, the ligated construct (pACCMV.pLpACSQAeq) DNA was extracted j
by ethanol precipitation. Sodium acetate solution (NaOAc) was added to a final 
volume of 0.3M. This was followed by addition of 2.5 volumes of ice-cold i
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absolute ethanol and thorough mixing. The tube was then placed at -20°C for 
15 minutes to allow precipitation of DNA. The sample was centrifuged at top 
speed in a bench top centrifuge at room temperature. The pellet was then 
washed with 70% ethanol and the tube placed on ice for 20 minutes, followed 
by centrifugation at top speed at 4°C. The supernatant was removed and the 
pellet allowed to air dry and was resuspended in 2^L of sterile de-ionised 
water.
This was followed by transformation of E. Colt DHSa by electroporation. The 
transformed bacteria were spread on LB-Agar plates with 50pg/mL ampicillin 
to allow selection. This is possible because pACCMV.pLpA contains an 
ampicillin resistance gene and therefore only bacteria transformed with the 
plasmid will survive the selection process. Ampicillin resistant colonies that 
contained the plasmid were picked and used to inoculate 5mL LB broth. This 
mixture with 50pg/mL ampicillin was allowed to shake overnight at 37°C. Small 
scale DNA preparation was carried out using Qiagen™ Qiaprep spin miniprep 
kit. Restriction analysis confirmed identity of the constructs and two of the 
cultures were selected and sub-cultured into 250mL LB broth with added 
50pg/mL ampicillin and large scale DNA preparation carried out using 
Qiagen™ Qiafilter maxi prep kit. Prepared plasmid was quantified and purity 
ascertained by measuring the optical density (OD) at 260 and 280nm.
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IjLig of each pACCMV.pLpACSQAeq and pJM17 plasmids were used to 
transfect HEK 293 cells seeded in 6 well plates using Qiagen™ superfect 
tranfection reagent. HEK cells were cultured in IDM Media (Gibco BRL) 
supplemented with 8% PCS, penicillin/streptomycin and L-glutamine and 
passaged using standard cell culture technique.
Plasmid pJM17 is derived from adenovirus type-5 genome with deletion of the 
E1 region of the genome. The absence of this region facilitates allow site- 
specific recombination and subsequent insertion of cDNAs. This contrasts with 
the pAdenovator vectors in which the E3 region is deleted in addition to the E1. 
pJM17 contains insertions and deletions in the E3 gene rendering it non­
functional. The E1 region of the genome is required for replication. Thus the 
resulting adenoviruses are fully infectious but unable to replicate. The HEK 
293 cell line was generated by transformation by a type 5 adenovirus and 
hence the HEK genome contains adenovirus type 5 genome. It is possible to 
propagate adenovirus within HEK 293 cells as the E1 function is 
complemented allowing the adenoviruses to replicate (Becker et a/., 1994).
Co-transfection of pACCMV.pLpACSQAeq and pJM17 is followed by 
homologous recombination to generate a functional adenovirus with the CSQ- 
Aeq cDNA incorporated. The cloning and transfection procedure is 
summarised in figure 6.3.
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Figure 6.3. Simplified scheme for cloning and generation of recombinant adenovirus
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6.2.2 Studying AdSRAeq expression
To ascertain whether the chimaeric protein was being expressed in the cardiac 
myocytes it was necessary to perform several expression studies.
Sterile ventricular myocytes were prepared and cultured in M199 as described 
in chapter 2. Cells were infected with Ad-CSQ-Aeq with a MOI of 100. Infected 
cells were used 24 hours post-infection for the described expression studies.
6.2.2.1 Western blot analysis of CSQ-Aeq expression
Lysates from Ad-CSQ-Aeq infected myocytes were prepared. Equal amounts 
of total protein from untransfected cells and cells infected with Ad-CSQ-Aeq 
were loaded onto a 10 well mini gel (Invitrogen). CSQ-Aeq protein was 
resolved using a 4-12% BIs-Tris gel and subjecting to SDS-PAGE. This was 
followed by blotting onto a nitrocellulose membrane. After blocking in Swiss 
buffer with 1 % BSA (see general methods chapter for solution composition) 
overnight at 4°C, the protein was detected using a rabbit antiserum to 
calsequestrin (SWant). The antiserum was diluted 1 in 40,000 in Swiss buffer 
and incubated at room temperature on a bench-top shaker for 2 hours.
After several washing steps, the membrane was probed with an anti-rabbit 
secondary antibody conjugated to horseradish peroxidase (Transduction 
laboratories) diluted 1 in 5,000 in Swiss buffer, for 1 hour at room temperature. 
The membrane was incubated for 1 minute in ECL reagent (Amersham) and 
exposed to photographic film.
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6.2.2 2 Immunofluorescence labelling of CSQ-Aeq
To verify the effectiveness of the adenovirus-mediated over-expression and its 
ability to target the SR of cardiomyocytes, Immunofluorescence labelling and 
fluorescence imaging was used to determine the distribution of the expressed 
protein.
As described previously, the Calsequestrin-Aequorin fusion also contains a 9 
amino acid HA1 epitope tag. This property was exploited in the 
immunofluorescent labelling protocol.
Infected ventricular myocytes were allowed to settle on pre-flamed slides. Cells 
were fixed for 30 minutes at room temperature in NaCI/Pi solution (140mM 
NaCI, 2.7mM KOI, 1GmM NazPOA, 1.8mM KH2PO4, pH 7.3) containing 2% 
paraformaldehyde. Slides were then washed 3 times with NaCI/Pi solution. 
The fixed cells were then permeabilised for 30 minutes at room temperature 
with 0.1% Triton X-100 prepared in NaCI/Pi solution. The cells were blocked 
for 2 hours at room temperature in NaCI/Pi solution with 10% Horse serum 
added. The slides were incubated overnight at 4°C with a rabbit polyclonal 
anti-HAI antibody (abeam) diluted 1 in 200 in Swiss buffer. Following this the 
slides were washed 3 times in NaCI/Pi solution. The samples were then 
incubated with Donkey FITC conjugated anti-rabbit antibody (abeam) diluted 1 
in 100 in Swiss buffer for 1 hour at room temperature. After incubation the 
slides were washed 3 times in NaCI/Pi solution. Coverslips (thickness 1.6) 
were mounted using the mounting medium VectaShield ™ (Vector laboratories)
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that also maintains the fluorescent properties of the FITC and prevents 
photobleaching when excited.
6.2.2.3 Visualisation of fluorescent labelled cardiomyocytes
The location of the FITC conjugated antibody was visualised using Biorad™ 
Radience 200 MP confocal microscopy system. Cells were visualised using a 
60x water objective lens and excited at 488nm with an Argon/Krypton laser 
(peak emission 488nm (5mVV)) and the fluorescence detected using a 
515±30nm band pass filter. Fluorescence through the Z-plane of the cells was 
recorded using the Biorad software Laser sharp 2000 and the images 
analysed using the Biorad software LaserPix.
Controls containing no antibodies, no primary antibody and no secondary 
antibody were carried out in parallel.
G.2.2.4 Calibration of the photoprotein
This particular aequorin mutant had previously been calibrated (Montero et a/., 
1996). However it was not clear from the publication whether purified 
recombinant protein or an in situ calibration was used. Calibration of the intra- 
SR probe within permeabilised cells was carried out using buffered Ca^" 
solutions in the presence of high concentrations of Ca^^ ionophore.
Ventricular myocytes were isolated and cultured in Medium 199 as described 
previously. The cultured myocytes were infected with Ad-CSQ-Aeq with an
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MOI of 100. 24 hours post infection the myocytes were washed in the mock 
intracellular solution described above but containing ImM EGTA. Ca^ "" buffer 
solutions were prepared as follows using nitrilo-triacetic acid (NTA) and 
CaNTA.
5N solution
5mM KsNTA 
lOOmM KOI 
4.16mM MgCE 
25mM HEPES 
30mM NaCI 
pH 7.0
lOOCaN solution
lOOmMCa K 3N TA  
25mM HEPES 
pH 7.0
6x10® cardiomyocytes were permeabilised by brief exposure to 0.01 mg/ml (3- 
escin and bathed in ImL 6N solution. 1|iM A23187 was added. lOOCaN 
solution was added in order to give the following N:CaN ratios and free [Ca^ "^ ] 
according to table 6.1. Free [Ca *^"] values were calculated using the 
programme React version 3.1
NTA:CaNTA ratio Volume lOOmM CaN 
added to give ratio (pL)
Free [Ca^*]
5NTA N/A 250nM
3N:1CaN 25 lOO i^M
1N:1CaN 25 282^iM
1N:3CaN 25 680fj,M
Table 6.1. Solutions used for in situ calibration of Aequorin and 
corresponding free [Ca^T|.
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The protocol was terminated by assaying the total amount of aequorin 
remaining on addition of 100 |liL of lOOmM CaCb. The calibration procedure 
was repeated several times with different batches of cells.
6.2.3 Studying SR dynamics
Calcium dynamics were studied on populations of cells 24 hours post infection. 
An outline of the experimental procedure used to study SR Ca^ "" dynamics and 
the cuvette based system used for the luminometer measurements are shown 
in figure 6.4.
Infected cardiomyocytes were incubated with 1^M coelenterazine n and the 
cells permeabilised by brief exposure to 0.01 mg/ml p-escin and bathed in a 
mock intracellular solution of the following composition: 5mM EGTA, 25mM 
HEPES, 5.5mM MgCb, lOOmM KOI pH 7.0. Bioluminescence was monitored 
using a luminometer. Compounds, which alter the Ca '^  ^ uptake and release 
properties of SR, were used in studying SR Ca^^ dynamics. These included 
thapsigargin, a description of which is given in chapter 4 and ruthenium red.
Ruthenium red is a polycationic compound which has been shown to inhibit the 
mitochondrial Ca^^ uniporter and the Ca^ "" release channels of the SR or 
Ryanodine receptors ((Kargadn et a/., 1998)). Ruthenium red was used at a 
concentration of SjuM.
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Figure 6.4. A. Outline of the experimental protocol used to study SR Ca^* 
dynamics. 6.4 B. Cuvette based luminometer system used to capture light 
emitted from aequorin 154
6.3 Results
6.3.1 Western blot analysis of CSQ-Aeq expression
Cell lysates were prepared and the equivalent of 1 x1 O'* cells were run per lane 
of 4-12% Bis-Tris gels. Samples from infected cells and uninfected cells were 
run in addition to 5pg SR preparation to aid identification of the calsequestrin. 
Following transfer to a nitrocellulose membrane and probing with a primary 
antibody to calsequestrin and a Horseradish peroxidase conjugated secondary 
antibody, the membrane was incubated with ECL reagent and an 
autoradiograph produced. A section of the autoradiograph is shown in figure 
6.5.
52 kDa
MOI UT SR 
100 Prep
Figure 6.5. Western blot using an antibody to calsequestrin.
Comparing the samples from MOI 100 and the uninfected (LIT) 
cardiomyocytes, it is clear that there is over-expression of the calsequestrin 
and since the protein is expressed as a chimera, also the aequorin. However it 
is somewhat puzzling that the protein does not appear to migrate according to
155
the expected molecular weight of approximately 75kDa. One possible 
explanation is degradation of the expressed protein.
6.3.2 Immunofluorescence labelling of CSQ-Aeq
A primary antibody to the HA1 tag was used to label to CSQ-Aeq fusion 
protein. The labelling pattern was detected using a secondary antibody 
conjugated to the fluorescent molecule FITC to aid visualisation by confocal 
microscopy. A confocal fluorescence image and the corresponding 
transmission image of a representative cell are shown in figure 6.6.
Confocal Fluorescence 
Image
Transmission image
Figure 6.6. immunofiuorescent labeiled section of a cardiac myocyte 
infected with Ad-CSQ-Aeq.
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These images reveal the pattern of expression of CSQ-Aeq in two major 
regions: perinuclear and in discrete bands in synchrony with the striation 
pattern.
6.3.3 Studying SR dynamics in Ad-CSQ-Aeq infected cells
As described in the methods section, cardiac myocytes expressing the 
aequorin chimaera were used to study SR Ca^ "" dynamics. Figure 6.7 shows a 
representative trace from an experiment carried out in the presence of 5|uM 
Ruthenium red. The protocol involved raising the [Ca2+]cYT from <1nM to 
380nM followed by thapsigargin addition. The protocol is terminated by 
addition of 1% Triton X-100 and raising the [Ca^ *"] to lOmM which assays the 
remaining unconsumed aequorin and thus allows calculation of the total counts 
present.
Panel A shows the raw count data at each time point. The raw counts curve is 
integrated to the total counts at each time point. This is shown by the grey 
curve on panel B. This data is then used to calculate the fractional 
luminescence (FL) values at each time point, which is shown by the black 
trace on panel B.
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Figure 6.7. Conversion of raw counts to fractional luminescence.
A. Raw count data for a typical experiment where the [Ca^^cyy was raised
from <1nM to 380nM followed by thapsigargin addition. This is followed by addition of 
1 % Triton X-100 and raising the [Ca^T to 10mM.
B. The grey trace shows the total counts at each time point. The black trace shows the 
fractional luminescence (FL) values at each time point.
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6.3.3.1 Conversion of fractional luminescence to [Ca^^sR
As discussed earlier in this chapter, the expressed protein within the SR was 
calibrated in the presence of Ca^ "^  ionophore using buffered Ca^ "" solutions. 
Figure 6.8A shows the fractional luminescence values obtained when the 
[Ca^ "^ ] is raised using buffered NTA and CaNTA solutions. Fractional 
luminescence value increases as the [Ca^^] increases as expected. Figure 
6.SB shows the calibration curve constructed from mean FL values obtained, 
this is shown in black. The grey trace is derived from the published calibration 
curve for this aequorin mutant (Montero et al. 1995). Whether this was 
constructed from purified recombinant protein is unclear. This may provide an 
explanation as to why the curve obtained using ionophore and cell populations 
is shifted to the right indicating an apparent lower Ca^ "^  sensitivity. The protein 
within the sub-cellular compartment may provide a different reaction 
environment, for example the pH may differ or other ions may vary. Subtle 
differences such as these could alter the Ca^^ affinity.
Figure 6.8C is the equation used to fit the data to the logistic curve with the 
following parameters obtained from the curve; A1 is the minimum FL value, A2 
the maximum FL value, Xo is the affinity of the indicator for Ca^  ^ and p is the 
slope of the curve. In the subsequent studies these values were used in an 
algorithm that converts FL obtained into [Ca^ j^sR.
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Figure 6.8. Calibration of Aequorin.
A. Fractional luminescence and total counts data with buffered Ca^"' solutions in the 
Presence of IjiM  A23187. B. [Ca^*] plotted against fractional luminescence. 0. Logistic curve 
Equation used to relate fractional luminescence to [Ca^T
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6.3.3.2 Identification as a Ca^* signal from SR
In initial studies, experiments were carried out in the presence and absence of 25pM 
thapsigargin to ensure that all of the Ca^ "^  sensitive signal was due to SR activity. Figure 7.9 
depicts results from experiments carried out in the presence and absence of thapsigargin. 
The traces are shown in grey and black respectively.
[C a%  = 380nM
20 s
Figure 6.9. Studies in the presence and absence of 25|liM thapsigargin
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6.3.3 3 Studies of [Ca^^sR in the presence of Ruthenium Red
it was decided to initially study SR dynamics in cardiac muscle in the 
presence and absence of ryanodine receptor activity. Inhibition of RyRa activity 
was achieved by inclusion of Ruthenium Red.
Using a protocol similar to that shown in figures 6.7 and 6.9, the peak [Ca^'’]sR 
was measured using two fixed values of [Ca^"’]cYT at 162nM and 380nM in 
mock intracellular solutions In the presence and absence of ruthenium red. 
The mean values of [Ca^ j^sR under these conditions are shown in figure 6.10 
and table 6.2.
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1.2x10^- 
1.0x10""- 
8.0x10"'- 
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Figure 6.10. Mean [Ca^lsR in the presence and absence of 5|liM ruthenium red.
Cytosolic [Ca^T ([Ca^^cYr) was clamped at 162nM and SSOnM.
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[Ca^^]cYT=162nM [Ca^*]cYT=380nM
[Ca^lsR n [Ca'^sR n
-RuR 2.40 ± 0.140 xIO-* 7 4.78 ± 0.289 X 10-^ 15
+RuR 5.20 ± 0.230 X 10"^ 6 1.21+0.180x10^ 14
Table 6.2. Mean [Ca^^sR in the presence and absence of ruthenium red.
AN OVA analysis indicated that addition of ruthenium red significantly 
increased the [Ca^^sR at both 160nM and 380nM. Furthermore, increasing 
[Ca^’"]cYT resulted in a significantly higher [Ca^"]sR both in the presence and 
absence of ruthenium red.
However, an interesting result is obtained in the prolonged presence of 
ruthenium red as illustrated in figure 6.11.
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Figure 6.11. Effects of ruthenium red
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Figure 6.11 A depicts the primary effect of ruthenium red addition, in the graph 
shown there is an increase in [Ca '^"]sR when the [Ca^"]cYT is increased to 
128nM and then 380nM. Ruthenium red addition causes a more than 2 fold 
increase in [Ca '^']sR at a [Ca^ "^ ]cYT of 380nM. In the record shown, the [Ca^"']sR 
increases from approximately 520pM to approximately 1.3mM. As discussed 
later, this can be accounted for by inhibition of Ca^^ release via RyR thus 
allowing SR to attain a higher steady state value of [Ca^ j^sR.
6.3.4 Analysis of Ca^* leak and uptake in the absence of RyRa activity
The leak and uptake profiles were examined in the presence of S i^M ruthenium 
red to inhibit RyRz -mediated Ca^ "^  leak. Figure 6.12A shows the raw leak and 
uptake phases of a representative experiment. Figure 6.12B shows in detail 
the individual uptake and leak phases of the curve.
Each phase of the curve was taken in turn and differentiated to obtain the rate 
of change of [Ca^ '^ JsR with respect to time. This differential was then plotted 
against the [Ca '^ l^sR to give the relationship between [Ca '^ j^sR and the rate of 
leak/uptake. The leak and uptake curves for the experiment shown in figure 
6.12A are shown in figure 6.12C.
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Figure 6.12. Analysis of leak and uptake data.
Raw leak and uptake data shown in panel A. The individual uptake and leak
phases shown in panel B. Differential of each uptake and leak plotted against [Ca^^gR shown
in panel C.
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6.3.4.1 Analysis of data to give a general curve for mean uptake and leak 
in the absence of RyRg activity
All data obtained in the studies were analysed as described below.
Leak data
Leak was measured in the presence of ruthenium red and 25pM 
thapsigargin that allows unopposed leakage from SR.
For each study, the rate of change of [Ca '^ j^sR was obtained by differentiation 
of the leak phase of each data set and with respect to [Ca^"]sR was plotted 
against [Ca^^sR. The resulting curves were fitted to a linear regression of the 
form y=a + bx. Values of a and b were noted for each study and mean values 
for these constants were calculated. A record from one of these studies and its 
corresponding linear fit is shown in figure 6.13.
d[Ca^\^clt
Y = A + BX4x10 'S 6.921 E-7 +/- 1.845E-8 
-0.012 +/- 5.988 E-5
3x10'®-
2x1 O'® -
1x10®-
0 6x10'^ 8x10"* 1x10'®
[CaX(M)
Figure 6.13. Leak profiie.
The raw data is shown in black and the linear fit is shown by the grey trace. 
The parameters of the fit and their error are shown on the curve.
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Application of this analysis technique to a number of leak phases revealed 
average leak characteristics shown in figure 6.14 where the mean slope has a 
value of 0.012 and the Intercept on the y-axis is close to zero.
d[Ca'1g/dt
(M.s")
4x10
Mean values 
B= 0 .0 1 3 + /-7 E -5  
A = 4E -7  + /-1E -8
0
1.6x10'"0.0
[C a "L  (l\ )^
Figure 6.14. Mean leak curve. The relationship between [Ca^^sR and the 
rate of Ca^  ^leak.
Dashed lines denote the standard error on the curve. (n=16)
Uptake data
After the leak analysis for a particular experiment the leak was subtracted from 
the corresponding uptake differential to reveal the relationship between 
SERCA2a Ca^^ uptake rate and [Ca^ ]^sR using the parameters from the leak 
curve using the equation for the linear fit y=a+bx, where x=[Ca^"']sR. The 
values ascertained for a and b for each experiment were used and subtracted 
from the uptake rate (y).
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The rate of change of [Ca '^*’]sR with respect to time was fitted to a logistic 
curve. A curve from a representative experiment is shown in figure 6.15 with 
the corresponding logistic fit.
The curve parameters from each fit were noted. Mean values for each were 
calculated and used to generate a mean curve shown in figure 6.16.
0.00004 
8.22E-6 ± 5.60E-7 
0.0006 ± 4.6619E-6 
5.08 ± 0.23
±3.15E-7
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3x10'^-
2x1 O'®-
2x1 a" 4x10" 6x10" 8x10" I x I T
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Figure 6.15. Leak rate vs. [Ca^^sR in the presence of S^ iM ruthenium red.
The grey curve is the logistic fit to the data shown in black. A1 Is the curve 
maximum, A2 the curve minimum, xo is the Kd value and p is the slope of the
curve.
The logistic equation used for the curve fit is as follows:
d[Ca^^sR/dt = A1-A2
(l+ICa^JsR/Xo)”)
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Figure 6.16. Mean uptake curve. The relationship between [Ca^^sR and 
the rate of Ca^* uptake.
The closed black circles denote mean A1 and A2 values respectively and the 
open circle denotes the xo or Kd value. Error bars are also shown.
d[Ca%/dt
(M.s')
4x10 '\ Uptake
3x10'"-
2x10'"-
1x10"-
Leak
1.2x10'" 1.6x10'"0.0
[Can,,(M)
Figure 6.17. Relationship between apparent Ca^* transport rates and 
[Ca'IsR
Derived from mean parameters for both the uptake and the leak curves. The 
red dotted arrow denotes the point of interception of the two curves and 
therefore the equilibrium [Ca^’']sR. Uptake rate is leak corrected. Leak and 
uptake measured in the presence of 5|iM ruthenium red. Leak measured also 
in the presence of 25|u.M thapsigargin.
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Figure 6.17 shows the mean relationship between the apparent Ca^ "" transport
rates and [Ca^’^ jsR derived from mean data.
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6.4 Discussion
The results In this chapter represent the first direct measurement of [Ca^ ]^sR 
within adult cardiac muscle. This has been possible by the generation of a 
protein-based Ca^ "" indicator targeted to the SR.
6.4.1 Selectivity of probe
The selectivity of the probe was confirmed using an inhibitor to specifically 
inhibit Ca^^ accumulation by SR, namely thapsigargin. The results from studies 
carried out in the presence and absence of thapsigargin are shown in figure 
6.9. The absence of any change in [Ca^ j^sR on raising the [Ca^"‘]cYrfrom <1nM 
to 380nM in the presence of 25|aM thapsigargin compared to the control 
experiment indicates that the Ca^ "^  sensitive signal can be solely attributed to 
SR.
6.4.2 Steady state [Ca^^sR in the absence of RyR2 activity
RyR2 was inhibited by the sustained presence of 5pilVI ruthenium red. There is 
a marked difference between the measured [Ca '^ j^sR with the [Ca^'^jcvr 
clamped at two values in the absence and presence of RyRz inhibitor. Mean 
[Ca '^ j^sR values derived from this data is shown in figure 6.10 and table 6.2. At 
both [Ca^ j^cYT values, in the absence of ruthenium red, the mean [Ca^^sR is 
lower compared to the mean [Ca^ '^jsR in the presence of ruthenium red.
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The lower [Ca^’^ ]sR observed in the absence of ruthenium red can be explained 
by a balance between SERCA-mediated Ca^^ uptake and RyR-mediated Ca^" 
release which results in a steady state value of [Ca "^']sR.
The [Ca '^']sR is more than two fold greater in the presence of ruthenium red at 
both values of [Ca^"]cYT. This can be accounted for by inhibition of flux through 
the RyR. This is consistent with the existence of a significant leak through 
RyR. Therefore blocking RyR-mediated Ca^ '*' leak with ruthenium red will 
increase the free [Ca^^sR. The turnover of SERCA will remain high, but we 
assume that the leak observed is not RyR-mediated, but is a background leak 
which is present even in the absence of RyR-mediated Ca^ '*' leak. This 
decrease in leak can explain how the higher [Ca^ '^ JsR is attained as a new 
steady state [Ca^^sR is reached.
The values of [Ca^%R observed are close to values reported by Shannon and 
Bers using SR vesicles. This group estimated that the [Ca^^] within the 
vesicles was in the range 0.7-1 mM ((Shannon & Bers, 1997). Given that these 
studies were carried out with a vesicle preparation with a different surface 
area/volume ratio to native SR and the number of functional RyR2 entities 
present was unknown, the values obtained in my own studies can be said to 
be in close agreement.
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6.4.3 Studies in the sustained presence of ruthenium red
In addition to the above experiments, studies were also carried out in the 
maintained presence of ruthenium red. Figure 6.11 depicts the results obtained 
under such conditions. The primary effect of ruthenium red addition is clear in 
figure 6.11 A. This effect is to increase the [Ca '^"]sR when [Ca^’*']cYT is clamped. 
This effect was also observed in the presence of lOOpM tetracaine (data not 
shown as n=2).
However, on prolonged incubation with 5|iM ruthenium red shown in figure
6.1 IB. There appears to be a biphasic effect. The initial rapid rise in [Ca^’"]sR is 
followed by a decline with a slower time course than the rise. This cannot be 
easily explained. Two possible scenarios could provide an explanation. The 
first involves a direct effect of ruthenium red on SERCA. Previously it has been 
demonstrated that ruthenium red decreases the Ga^”^ sensitivity of SR Ca^^ 
uptake in a dose dependent manner but the Vmax and Hill coefficient remain 
unchanged (Kargarcin, All & Kargacin 1998). Partial inhibition of SERCA would 
explain the slow time course compared to the decline in [Ca^‘^ ]sR when 
thapsigargin Is added (figure 6.11A). One of the conclusions from this study 
was that It was unlikely that the effect of ruthenium red on the Ca^ "" sensitivity 
of SR uptake was mediated through the ryanodine receptor, as experimental 
conditions did not favour ryanodine receptor opening. Thus this effect on Ca^'’ 
uptake is most likely to result from direct action of ruthenium red on SERCA 
and occurs independently of the effect on the ryanodine receptor.
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It has also been demonstrated that ruthenium red Inhibits SERCA reversal by 
Pi and ADP (Alves and de Meis 1986).
An alternative to the above explanation would be that ruthenium red in some 
way activates an as yet unidentified Ca^’*' leak pathway from SR. This has not 
yet been reported and evidence from oxalate loaded SR with ruthenium red 
addition Indicates an increase in the rate of uptake consistent with inhibition of 
RyR-mediated leak and no increased leak. However the intra-SR 
concentration has not been measured under these conditions, and since 
oxalate is used as a trapping ion to clamp [Ca^^sR at a low level. If another 
leak pathway is being activated by ruthenium red the [Ca^"']sR may not be 
sufficiently high for such a leak to occur.
6.4.4 Analysis of SR Ca^* leak and uptake in the absence of RyR% activity
The mean relationship between the leak and uptake rates and [Ca '^ j^sR is 
shown in figure 6.17.
6.4.4.1 Uptake characteristics
The leak-corrected uptake curve appears to be non-linear and was fitted to a 
logistic curve. On examination of the mean uptake curve shown in figure 6.16 
the first striking observation is the steep dependence of the rate of Ca^^ 
transport into the SR on the [Ca^ j^sR. The apparent rate of uptake is very high 
when [Ca^ "^ ]sR is low. The value from the mean curve of the maximum uptake 
rate is 3B\jM  s'  ^ that corresponds to of 2.3mM min'V The rate decreases as 
[Ca '^"]sR increases and hence the store refills. At [Ca^‘"]sR values > 1.2mM
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there is virtually no Ca^ "" uptake and the rate tends towards zero. The results 
suggest a form of lumenal regulation of SERCA2a activity. The result would 
suggest that this negative feedback of Ca^^ in the lumen of the store on 
SERCA2a controls SR Ca^ "" content.
A simple lumenal dependence on [Ca^^] would not explain the relationship 
between [Ca^’^ jsR and the rate of Ca^ "^  uptake. If this were the case the 
relationship would be linear. Another factor that could explain the observed 
result could be the presence of the Ca^ "^  buffering protein calsequestrin. In the 
[Ca^ ]^sR range 0-0.4mM the rate of Ca^'' uptake does not alter much and looks 
relatively constant. There is a similar scenario between the concentration 
ranges 1.2-1.8mM where the rate tends towards zero and reaches a plateau.
Within the intermediate [Ca^ ]^sR between 0.4-1.2mM, as [Ca^'‘]sR is increased 
the rate of uptake decreases sharply, before tending towards zero at [Ca "^']sR 
<1.2mM. It is conceivable that the buffering capacity of calsequestrin lies 
within this intermediate range of [Ca^ j^sR therefore as the buffer becomes 
saturated, the free [Ca^’^ jsR rises and has a negative feedback effect on 
SERCA2a. Alternatively the rapid decrease in the rate of Ca^ '*' uptake may be 
due to a direct inhibition by [Ca^%R on SERCA2a. This direct effect was 
suggested by Hasselbach for work carried out with skeletal SR vesicles (Katz 
et ai., 1977) & (Hasselbach, 1978).
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G.4.4.2 Leak characteristics
In contrast to the uptake, the apparent rate of leak in the absence of ryanodine 
receptor activity, shows an inverse dependence on [Ca^^sR. At very low 
ECa^ "]sR values and thus the store depleted, the apparent leak rate is 
negligible. As the store refills, the [Ca '^"]sR value increases as does the 
apparent rate of leak. There exists a linear relationship between the leak rate 
and the [Ca^’"]sR.
The kinetics of the leak suggests a simple leak channel. This has not been 
observed before. It represents a background Ca^  ^ leak. Previous work on SR 
Ca '^" leak suggests that in the absence of RyRz activity one of the major routes 
for Ca^"' extrusion from SR occurs via SERCA2a pump reversal (Hasselbach, 
1978). However, the leak studied here was carried out in the presence of 
thapsigargin. It has been demonstrated that thapsigargin presence blocks 
pump reversal (Smith et a l, 2000) and yet a substantial Ca^ '*' leak remains. It is 
unlikely that the extrusion occurs via a population of RyRa due to incomplete 
inhibition as one would expect the dependence of the leak rate on [Ca^ j^sR to 
be non-linear under this condition.
Studies carried out by Pessah and colleagues (1997) suggest the existence of 
a Ca^^ leak channel in skeletal muscle. The pathway is unmasked by 
thapsigargin addition. The ‘channel’ is insensitive to inhibition by ruthenium red 
and high concentrations of ryanodine. Addition of the protein bastadin 5 in 
conjunction with high concentrations of ryanodine or ruthenium red eliminates
177
this ryanodine insensitive leak. The group suggest the identity of ‘channel’ as 
RyRi that is somehow dysfunctional and permanently open, but there has 
been no evidence of such a channel existing in cardiac muscle.
6.4 4.3 Equilibrium value of [Ca^^sR
The equilibrium value for [Ca '^"]sR occurs when the rate of uptake and rate of 
leak are apparently balanced to maintain a steady state value. This value is 
when both the leak and uptake curves intercept. From the mean curves shown 
in figure 6.17, the equilibrium value is shown by the dotted red line and is 
occurs at a [Ca^ j^sR of approximately 0.96mM. This is similar to the mean 
values calculated from the steady state [Ca^^sR at a [Ca^'^jcrr of 380nM shown 
in figure 6.10 where [Ca^"]sR=1.21mM and also estimates using MgFura-2 
entrapped vesicle preparations (Shannon and Bers, 1997) This group 
estimated that at a cytosolic [Ca '^*'] of 100-150nM, which is a good estimate of 
end diastolic [Ca *^"] in the cytoplasmic compartment, the intra-vesicular [Ca^"] 
was in the range of 0.7-1 mM.
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Chapter 7 
General Conclusions
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Chapter 7-General Conclusions
The original aim was to measure the [Ca^^] within the different organelles of 
cardiac muscle.
7.1 Use of fluorescent indicators to study organelle Ca^* dynamics
Incubating populations of cel is with acetoxoymethyl ester (AM) derivatives of 
FURA based dyes was used to introduce Ca^^ sensitive indicators inside the 
organelles. The use of indicators with very different Ca^ "* affinities should allow 
the differentiation of signals from SR, mitochondria and any other passive 
compartment. The results from this part of the study indicated that this 
approach could not be used to measure Ca^^ within the SR lumen. However, 
good signals from mitochondria were achieved. Furthermore, a large passive, 
slowly exchanging compartment was unmasked. The cellular structure 
represented by this is unclear.
Work in isolated SR and mitochondria confirmed the ability of mitochondria to 
cleave acetoxoymethyl derivatives of FURA indicators. Isolated SR did not 
accumulate indicator suggesting low intrinsic esterase activity.
The general conclusion from this work is that AM loading of fluorescent 
indicators is not a feasible approach for studying SR Ca^^ dynamics in cardiac 
muscle. However, excellent mitochondrial signals were obtained suggesting 
that this may be a minimally invasive technique to study mitochondrial Ca^* 
dynamics.
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7.2 [Ca^^sR studies using a targeted probe
An adenovirus was generated which allowed successful expression and 
targeting of aequorin to SR. This generated the first direct measurement of 
[Ca^^] within a native SR structure using a bioluminescent Ca^ "^  indicator. A 
major limitation of this technique is the relatively short time period over which 
measurements can be made. This work also revealed the lumenal 
dependence of Ca '^* uptake and leak from the SR.
7.3 Future directions
There is clearly further scope for work in the areas of organelle Ca^^ dynamics 
explored in cardiac muscle. Future studies include determination of the cellular 
structure(s) responsible for the slow, passive exchange of Ca^ "^ . Also 
identification of the RyRa-independent Ca^^ leak from the SR and 
determination of the mechanism underlying the lumenal Ca^^ regulation of 
SERCA2a.
Clarification of the lumenal control processes will enhance our understanding 
of the functions of SR in physiological and pathophysiological conditions (e.g. 
heart failure)
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